Advanced Search (OLGA)

Gene: SLCO2B1 (solute carrier organic anion transporter family member 2B1) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

SLCO2B1

Name:

solute carrier organic anion transporter family member 2B1

RGD ID:

736486

HGNC Page

HGNC:10962

Description:

Enables prostaglandin transmembrane transporter activity and sodium-independent organic anion transmembrane transporter activity. Involved in organic anion transport and transmembrane transport. Located in apical plasma membrane and basal plasma membrane. Biomarker of liver cancer and pancreatic cancer.

Type:

protein-coding

RefSeq Status:

REVIEWED

Previously known as:

DKFZp686E0517; KIAA0880; OATP-B; OATP-RP2; OATP2B1; OATPB; OATPRP2; organic anion transporter B; organic anion transporter polypeptide-related protein 2; organic anion transporting polypeptide 2B1; SLC21A9; solute carrier family 21 (organic anion transporter), member 9; solute carrier family 21 member 9; solute carrier organic anion transporter family, member 2B1

RGD Orthologs

Alliance Orthologs

More Info

more info ...

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	11	75,151,107 - 75,206,549 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	11	75,100,563 - 75,206,549 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	11	74,862,152 - 74,917,594 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	11	74,539,811 - 74,594,947 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	11	74,539,810 - 74,594,945	NCBI
Celera	11	72,168,595 - 72,224,004 (+)	NCBI		Celera
Cytogenetic Map	11	q13.4	NCBI
HuRef	11	71,159,611 - 71,215,067 (+)	NCBI		HuRef
CHM1_1	11	74,745,634 - 74,801,048 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	11	75,080,709 - 75,136,155 (+)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLCO2B1	Human	liver cancer	disease_progression	IEP		152995425	mRNA:decreased expression:liver (human)	RGD
SLCO2B1	Human	pancreatic cancer		IEP		152995425	mRNA:decreased expression:pancreas (human)	RGD

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLCO2B1	Human	3-methylglutaconic aciduria type 7b		IAGP	RGD:156450612	8554872	ClinVar Annotator: match by term: 3-methylglutaconic aciduria, type VIIB	ClinVar	PMID:28492532
SLCO2B1	Human	intellectual disability		IAGP	RGD:42723466	8554872	ClinVar Annotator: match by term: Intellectual disability	ClinVar

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLCO2B1	Human	(+)-schisandrin B	multiple interactions	ISO	RGD:621391	6480464	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLCO2B1 mRNA]	CTD	PMID:31150632
SLCO2B1	Human	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:736487	6480464	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLCO2B1 mRNA	CTD	PMID:36331819
SLCO2B1	Human	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:736487	6480464	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLCO2B1 mRNA	CTD	PMID:22206623
SLCO2B1	Human	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:621391	6480464	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of SLCO2B1 mRNA	CTD	PMID:27840820
SLCO2B1	Human	1,2-dimethylhydrazine	decreases expression	ISO	RGD:736487	6480464	1,2-Dimethylhydrazine results in decreased expression of SLCO2B1 mRNA	CTD	PMID:22206623
SLCO2B1	Human	17beta-estradiol	decreases expression	EXP		6480464	Estradiol results in decreased expression of SLCO2B1 mRNA	CTD	PMID:20106945
SLCO2B1	Human	17beta-estradiol	decreases expression	ISO	RGD:736487	6480464	Estradiol results in decreased expression of SLCO2B1 mRNA	CTD	PMID:39298647
SLCO2B1	Human	2,2',4,4',5,6'-Hexabromodiphenyl ether	increases import	EXP		6480464	SLCO2B1 results in increased import of 2,2',4,4',5,6'-hexabromodiphenyl ether	CTD	PMID:20176623
SLCO2B1	Human	2,2',4,4',5,6'-Hexabromodiphenyl ether	multiple interactions	EXP		6480464	2,2',4,4',5,6'-hexabromodiphenyl ether inhibits the reaction [SLCO2B1 results in increased import of estrone sulfate]	CTD	PMID:20176623
SLCO2B1	Human	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	EXP		6480464	2,2',4,4'-tetrabromodiphenyl ether inhibits the reaction [SLCO2B1 results in increased import of estrone sulfate]	CTD	PMID:20176623
SLCO2B1	Human	2,2',4,4'-Tetrabromodiphenyl ether	increases uptake	ISO	RGD:736487	6480464	SLCO2B1 protein results in increased uptake of 2,2',4,4'-tetrabromodiphenyl ether	CTD	PMID:21884716
SLCO2B1	Human	2,2',4,4'-Tetrabromodiphenyl ether	increases import	EXP		6480464	SLCO2B1 results in increased import of 2,2',4,4'-tetrabromodiphenyl ether	CTD	PMID:20176623
SLCO2B1	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:736487	6480464	Tetrachlorodibenzodioxin results in decreased expression of SLCO2B1 mRNA	CTD	PMID:19770486\|PMID:26290441
SLCO2B1	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:621391	6480464	Tetrachlorodibenzodioxin results in decreased expression of SLCO2B1 mRNA	CTD	PMID:21215274
SLCO2B1	Human	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:621391	6480464	Tetrachlorodibenzodioxin affects the expression of SLCO2B1 mRNA	CTD	PMID:34747641
SLCO2B1	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:621391	6480464	Tetrachlorodibenzodioxin results in increased expression of SLCO2B1 mRNA	CTD	PMID:32109520
SLCO2B1	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		6480464	Tetrachlorodibenzodioxin results in decreased expression of SLCO2B1 mRNA	CTD	PMID:16837569\|PMID:20106945\|PMID:25803276\|PMID:26159488\|PMID:27450509
SLCO2B1	Human	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases uptake	ISO	RGD:736487	6480464	SLCO2B1 protein results in increased uptake of 2,2',4,4',5-brominated diphenyl ether	CTD	PMID:21884716
SLCO2B1	Human	2,4-dinitrotoluene	affects expression	ISO	RGD:621391	6480464	2,4-dinitrotoluene affects the expression of SLCO2B1 mRNA	CTD	PMID:21346803
SLCO2B1	Human	2,6-dinitrotoluene	affects expression	ISO	RGD:621391	6480464	2,6-dinitrotoluene affects the expression of SLCO2B1 mRNA	CTD	PMID:21346803
SLCO2B1	Human	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:736487	6480464	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of SLCO2B1 mRNA	CTD	PMID:15919853
SLCO2B1	Human	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:736487	6480464	bisphenol S results in increased expression of SLCO2B1 mRNA	CTD	PMID:30951980
SLCO2B1	Human	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:736487	6480464	bisphenol S results in decreased expression of SLCO2B1 mRNA	CTD	PMID:39298647
SLCO2B1	Human	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:736487	6480464	Fenretinide results in decreased expression of SLCO2B1 mRNA	CTD	PMID:28973697
SLCO2B1	Human	[2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol	multiple interactions	EXP		6480464	Mefloquine affects the reaction [SLCO2B1 protein results in increased uptake of estrone sulfate]	CTD	PMID:27504015
SLCO2B1	Human	acetamide	decreases expression	ISO	RGD:621391	6480464	acetamide results in decreased expression of SLCO2B1 mRNA	CTD	PMID:31881176
SLCO2B1	Human	adefovir pivoxil	increases expression	EXP		6480464	adefovir dipivoxil results in increased expression of SLCO2B1 mRNA	CTD	PMID:25596134
SLCO2B1	Human	aflatoxin B1	affects expression	EXP		6480464	Aflatoxin B1 affects the expression of SLCO2B1 protein	CTD	PMID:20106945
SLCO2B1	Human	aflatoxin B1	decreases expression	EXP		6480464	Aflatoxin B1 results in decreased expression of SLCO2B1 mRNA	CTD	PMID:22100608\|PMID:27153756
SLCO2B1	Human	aflatoxin B1	increases methylation	EXP		6480464	Aflatoxin B1 results in increased methylation of SLCO2B1 gene	CTD	PMID:27153756
SLCO2B1	Human	aflatoxin B1	decreases expression	ISO	RGD:736487	6480464	Aflatoxin B1 results in decreased expression of SLCO2B1 mRNA	CTD	PMID:19770486
SLCO2B1	Human	all-trans-retinoic acid	multiple interactions	ISO	RGD:736487	6480464	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLCO2B1 mRNA	CTD	PMID:36189433
SLCO2B1	Human	all-trans-retinoic acid	increases expression	ISO	RGD:736487	6480464	Tretinoin results in increased expression of SLCO2B1 mRNA	CTD	PMID:36189433
SLCO2B1	Human	amiodarone	increases uptake	EXP		6480464	SLCO2B1 protein results in increased uptake of Amiodarone	CTD	PMID:19285480
SLCO2B1	Human	ammonium chloride	affects expression	ISO	RGD:621391	6480464	Ammonium Chloride affects the expression of SLCO2B1 mRNA	CTD	PMID:16483693
SLCO2B1	Human	antirheumatic drug	decreases expression	EXP		6480464	Antirheumatic Agents results in decreased expression of SLCO2B1 mRNA	CTD	PMID:24449571
SLCO2B1	Human	aripiprazole	decreases expression	ISO	RGD:621391	6480464	Aripiprazole results in decreased expression of SLCO2B1 mRNA	CTD	PMID:17868501
SLCO2B1	Human	arsane	increases transport	EXP		6480464	SLCO2B1 protein results in increased transport of Arsenic	CTD	PMID:22214486
SLCO2B1	Human	arsenic atom	increases transport	EXP		6480464	SLCO2B1 protein results in increased transport of Arsenic	CTD	PMID:22214486
SLCO2B1	Human	arsenous acid	increases expression	EXP		6480464	Arsenic Trioxide results in increased expression of SLCO2B1 mRNA	CTD	PMID:22214486\|PMID:27829220
SLCO2B1	Human	atorvastatin calcium	multiple interactions	EXP		6480464	glimepiride inhibits the reaction [SLCO2B1 protein results in increased uptake of Atorvastatin]; Glyburide inhibits the more ...	CTD	PMID:23121773\|PMID:25106415
SLCO2B1	Human	atorvastatin calcium	increases uptake	EXP		6480464	SLCO2B1 protein results in increased uptake of Atorvastatin	CTD	PMID:23121773\|PMID:25106415
SLCO2B1	Human	Azoxymethane	multiple interactions	ISO	RGD:736487	6480464	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLCO2B1 more ...	CTD	PMID:29950665
SLCO2B1	Human	benzo[a]pyrene	decreases expression	ISO	RGD:736487	6480464	Benzo(a)pyrene results in decreased expression of SLCO2B1 mRNA	CTD	PMID:19770486
SLCO2B1	Human	benzo[a]pyrene	decreases methylation	EXP		6480464	Benzo(a)pyrene results in decreased methylation of SLCO2B1 3' UTR	CTD	PMID:27901495
SLCO2B1	Human	benzo[a]pyrene	affects methylation	EXP		6480464	Benzo(a)pyrene affects the methylation of SLCO2B1 promoter	CTD	PMID:27901495
SLCO2B1	Human	benzo[a]pyrene	decreases expression	EXP		6480464	Benzo(a)pyrene results in decreased expression of SLCO2B1 mRNA	CTD	PMID:20106945\|PMID:22316170\|PMID:26238291\|PMID:32234424
SLCO2B1	Human	benzo[a]pyrene	increases expression	ISO	RGD:736487	6480464	Benzo(a)pyrene results in increased expression of SLCO2B1 mRNA	CTD	PMID:22228805
SLCO2B1	Human	beta-naphthoflavone	increases expression	ISO	RGD:736487	6480464	beta-Naphthoflavone results in increased expression of SLCO2B1 mRNA	CTD	PMID:15919853
SLCO2B1	Human	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:736487	6480464	Diethylhexyl Phthalate results in decreased expression of SLCO2B1 mRNA	CTD	PMID:15919853
SLCO2B1	Human	bisphenol A	multiple interactions	ISO	RGD:736487	6480464	[potassium bromate co-treated with bisphenol A] affects the expression of SLCO2B1 mRNA; [XRCC6 gene mutant more ...	CTD	PMID:27082013
SLCO2B1	Human	bisphenol A	decreases expression	ISO	RGD:736487	6480464	bisphenol A results in decreased expression of SLCO2B1 mRNA	CTD	PMID:33221593
SLCO2B1	Human	bisphenol A	decreases expression	ISO	RGD:621391	6480464	bisphenol A results in decreased expression of SLCO2B1 mRNA	CTD	PMID:25181051\|PMID:30816183\|PMID:32528016\|PMID:34947998
SLCO2B1	Human	bisphenol A	affects expression	EXP		6480464	bisphenol A affects the expression of SLCO2B1 mRNA	CTD	PMID:30903817
SLCO2B1	Human	bisphenol A	increases expression	ISO	RGD:736487	6480464	bisphenol A results in increased expression of SLCO2B1 mRNA	CTD	PMID:30951980
SLCO2B1	Human	bisphenol F	increases expression	ISO	RGD:736487	6480464	bisphenol F results in increased expression of SLCO2B1 mRNA	CTD	PMID:30951980
SLCO2B1	Human	bleomycin A2	multiple interactions	EXP		6480464	Bleomycin inhibits the reaction [SLCO2B1 protein results in increased uptake of Cascade Blue]	CTD	PMID:30863990
SLCO2B1	Human	bromosulfophthalein	affects import	EXP		6480464	SLCO2B1 protein affects the import of Sulfobromophthalein	CTD	PMID:16046661
SLCO2B1	Human	bromosulfophthalein	decreases activity	EXP		6480464	Sulfobromophthalein results in decreased activity of SLCO2B1 protein	CTD	PMID:31364238
SLCO2B1	Human	bromosulfophthalein	multiple interactions	EXP		6480464	Budesonide inhibits the reaction [SLCO2B1 protein results in increased uptake of Sulfobromophthalein]; Cyclosporine inhibits the more ...	CTD	PMID:21430235\|PMID:23121773\|PMID:25106415\|PMID:27450509
SLCO2B1	Human	bromosulfophthalein	increases uptake	EXP		6480464	SLCO2B1 protein results in increased uptake of Sulfobromophthalein	CTD	PMID:21430235\|PMID:23121773
SLCO2B1	Human	budesonide	multiple interactions	EXP		6480464	Budesonide inhibits the reaction [SLCO2B1 protein results in increased uptake of Mesalamine]; Budesonide inhibits the more ...	CTD	PMID:21430235
SLCO2B1	Human	butylated hydroxyanisole	increases expression	ISO	RGD:736487	6480464	Butylated Hydroxyanisole results in increased expression of SLCO2B1 mRNA	CTD	PMID:15919853
SLCO2B1	Human	calcitriol	decreases expression	EXP		6480464	Calcitriol results in decreased expression of SLCO2B1 mRNA	CTD	PMID:26485663
SLCO2B1	Human	capecitabine	multiple interactions	EXP		6480464	Capecitabine inhibits the reaction [SLCO2B1 protein results in increased uptake of Cascade Blue]	CTD	PMID:30863990
SLCO2B1	Human	carbamazepine	increases expression	EXP		6480464	Carbamazepine results in increased expression of SLCO2B1 mRNA	CTD	PMID:17112801
SLCO2B1	Human	carbon nanotube	affects expression	ISO	RGD:736487	6480464	Nanotubes, Carbon affects the expression of SLCO2B1 mRNA	CTD	PMID:25554681
SLCO2B1	Human	carbon nanotube	decreases expression	ISO	RGD:736487	6480464	Nanotubes, Carbon analog results in decreased expression of SLCO2B1 mRNA	CTD	PMID:25554681\|PMID:25620056
SLCO2B1	Human	cascade blue	increases uptake	EXP		6480464	SLCO2B1 protein results in increased uptake of Cascade Blue	CTD	PMID:30863990
SLCO2B1	Human	cascade blue	multiple interactions	EXP		6480464	Bleomycin inhibits the reaction [SLCO2B1 protein results in increased uptake of Cascade Blue]; Capecitabine inhibits more ...	CTD	PMID:30863990
SLCO2B1	Human	CGP 52608	multiple interactions	EXP		6480464	CGP 52608 promotes the reaction [RORA protein binds to SLCO2B1 gene]	CTD	PMID:28238834
SLCO2B1	Human	CHIR 99021	multiple interactions	EXP		6480464	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA more ...	CTD	PMID:34480604
SLCO2B1	Human	chlorpromazine	decreases expression	ISO	RGD:621391	6480464	Chlorpromazine results in decreased expression of SLCO2B1 mRNA	CTD	PMID:25596134
SLCO2B1	Human	cholic acid	increases uptake	EXP		6480464	SLCO2B1 protein results in increased uptake of Cholic Acid	CTD	PMID:24285294
SLCO2B1	Human	cholic acid	multiple interactions	EXP		6480464	Rutin promotes the reaction [SLCO2B1 protein results in increased uptake of Cholic Acid]	CTD	PMID:24285294
SLCO2B1	Human	choline	multiple interactions	ISO	RGD:621391	6480464	[Choline deficiency co-treated with Methionine deficiency] results in decreased expression of SLCO2B1 mRNA	CTD	PMID:38663832
SLCO2B1	Human	chromium(6+)	affects expression	ISO	RGD:736487	6480464	chromium hexavalent ion affects the expression of SLCO2B1 mRNA	CTD	PMID:28472532
SLCO2B1	Human	cidofovir anhydrous	increases expression	EXP		6480464	Cidofovir results in increased expression of SLCO2B1 mRNA	CTD	PMID:25596134
SLCO2B1	Human	ciprofibrate	decreases expression	ISO	RGD:736487	6480464	ciprofibrate results in decreased expression of SLCO2B1 mRNA	CTD	PMID:15919853
SLCO2B1	Human	clofibrate	decreases expression	ISO	RGD:736487	6480464	Clofibrate results in decreased expression of SLCO2B1 mRNA	CTD	PMID:15919853
SLCO2B1	Human	clofibric acid	affects expression	ISO	RGD:621391	6480464	Clofibric Acid affects the expression of SLCO2B1 mRNA	CTD	PMID:17602206
SLCO2B1	Human	cobalt dichloride	increases expression	EXP		6480464	cobaltous chloride results in increased expression of SLCO2B1 mRNA	CTD	PMID:22941251
SLCO2B1	Human	cobalt dichloride	decreases expression	ISO	RGD:621391	6480464	cobaltous chloride results in decreased expression of SLCO2B1 mRNA	CTD	PMID:24386269
SLCO2B1	Human	copper(II) sulfate	decreases expression	EXP		6480464	Copper Sulfate results in decreased expression of SLCO2B1 mRNA	CTD	PMID:19549813
SLCO2B1	Human	cyclosporin A	multiple interactions	EXP		6480464	Cyclosporine inhibits the reaction [SLCO2B1 protein results in increased uptake of Mesalamine]; Cyclosporine inhibits the more ...	CTD	PMID:21430235\|PMID:24947867
SLCO2B1	Human	cyclosporin A	decreases expression	ISO	RGD:621391	6480464	Cyclosporine results in decreased expression of SLCO2B1 mRNA	CTD	PMID:25596134
SLCO2B1	Human	cyclosporin A	affects expression	EXP		6480464	Cyclosporine affects the expression of SLCO2B1 mRNA	CTD	PMID:25596134
SLCO2B1	Human	cyclosporin A	decreases expression	EXP		6480464	Cyclosporine results in decreased expression of SLCO2B1 mRNA	CTD	PMID:20106945\|PMID:25562108
SLCO2B1	Human	cyclosporin A	increases expression	EXP		6480464	Cyclosporine results in increased expression of SLCO2B1 mRNA	CTD	PMID:24907557
SLCO2B1	Human	cyclosporin A	decreases expression	ISO	RGD:736487	6480464	Cyclosporine results in decreased expression of SLCO2B1 mRNA	CTD	PMID:19770486
SLCO2B1	Human	daidzein	increases transport	EXP		6480464	SLCO2B1 protein results in increased transport of daidzein metabolite	CTD	PMID:25319728
SLCO2B1	Human	daidzein	multiple interactions	EXP		6480464	daidzein inhibits the reaction [SLCO2B1 protein results in increased transport of estrone sulfate]; daidzein metabolite more ...	CTD	PMID:25319728
SLCO2B1	Human	dexamethasone	decreases expression	ISO	RGD:736487	6480464	Dexamethasone results in decreased expression of SLCO2B1 mRNA	CTD	PMID:15919853
SLCO2B1	Human	dextran sulfate	multiple interactions	ISO	RGD:736487	6480464	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLCO2B1 more ...	CTD	PMID:29950665
SLCO2B1	Human	dextran sulfate	decreases expression	ISO	RGD:736487	6480464	Dextran Sulfate results in decreased expression of SLCO2B1 mRNA; Dextran Sulfate results in decreased expression more ...	CTD	PMID:38844255
SLCO2B1	Human	dextran sulfate	increases expression	EXP		6480464	Dextran Sulfate results in increased expression of SLCO2B1 mRNA; Dextran Sulfate results in increased expression more ...	CTD	PMID:38423481
SLCO2B1	Human	dextran sulfate	multiple interactions	EXP		6480464	Rifampin inhibits the reaction [Dextran Sulfate results in increased expression of SLCO2B1 mRNA]	CTD	PMID:38423481
SLCO2B1	Human	diarsenic trioxide	increases expression	EXP		6480464	Arsenic Trioxide results in increased expression of SLCO2B1 mRNA	CTD	PMID:22214486\|PMID:27829220
SLCO2B1	Human	dibenz[a,h]anthracene	increases expression	ISO	RGD:736487	6480464	1,2,5,6-dibenzanthracene results in increased expression of SLCO2B1 mRNA	CTD	PMID:26377693
SLCO2B1	Human	dioxygen	increases expression	EXP		6480464	Oxygen deficiency results in increased expression of SLCO2B1 mRNA	CTD	PMID:25596134
SLCO2B1	Human	endosulfan	decreases expression	ISO	RGD:621391	6480464	Endosulfan results in decreased expression of SLCO2B1 mRNA	CTD	PMID:29391264
SLCO2B1	Human	epoxiconazole	decreases expression	ISO	RGD:736487	6480464	epoxiconazole results in decreased expression of SLCO2B1 mRNA	CTD	PMID:35436446
SLCO2B1	Human	estrone 3-sulfate	multiple interactions	EXP		6480464	2,2',4,4',5,6'-hexabromodiphenyl ether inhibits the reaction [SLCO2B1 results in increased import of estrone sulfate]; 2,2',4,4'-tetrabromodiphenyl ether more ...	CTD	PMID:20176623\|PMID:24265111\|PMID:24285294\|PMID:24947867\|PMID:25319728\|PMID:27450509\|PMID:27504015
SLCO2B1	Human	estrone 3-sulfate	increases uptake	EXP		6480464	SLCO2B1 protein results in increased uptake of estrone sulfate	CTD	PMID:24285294\|PMID:27504015
SLCO2B1	Human	estrone 3-sulfate	increases import	EXP		6480464	SLCO2B1 protein results in increased import of estrone sulfate; SLCO2B1 results in increased import of more ...	CTD	PMID:16714376\|PMID:20176623\|PMID:27450509
SLCO2B1	Human	ethanol	increases expression	ISO	RGD:736487	6480464	Ethanol results in increased expression of SLCO2B1 mRNA	CTD	PMID:30319688
SLCO2B1	Human	ethanol	increases expression	ISO	RGD:621391	6480464	Ethanol results in increased expression of SLCO2B1 mRNA	CTD	PMID:34217791
SLCO2B1	Human	ethanol	multiple interactions	EXP		6480464	Meclizine promotes the reaction [Ethanol results in increased expression of SLCO2B1 mRNA]; NR1I2 protein affects more ...	CTD	PMID:34217791
SLCO2B1	Human	ethanol	increases expression	EXP		6480464	Ethanol results in increased expression of SLCO2B1 mRNA; Ethanol results in increased expression of SLCO2B1 more ...	CTD	PMID:34217791
SLCO2B1	Human	ethoxyquin	increases expression	ISO	RGD:736487	6480464	Ethoxyquin results in increased expression of SLCO2B1 mRNA	CTD	PMID:15919853
SLCO2B1	Human	etoposide	multiple interactions	EXP		6480464	Etoposide inhibits the reaction [SLCO2B1 protein results in increased uptake of Cascade Blue]	CTD	PMID:30863990
SLCO2B1	Human	fenofibrate	decreases expression	EXP		6480464	Fenofibrate results in decreased expression of SLCO2B1 mRNA	CTD	PMID:25596134
SLCO2B1	Human	fenofibrate	decreases expression	ISO	RGD:621391	6480464	Fenofibrate results in decreased expression of SLCO2B1 mRNA	CTD	PMID:25596134
SLCO2B1	Human	fenthion	decreases expression	ISO	RGD:736487	6480464	Fenthion results in decreased expression of SLCO2B1 mRNA	CTD	PMID:34813904
SLCO2B1	Human	flutamide	decreases expression	ISO	RGD:621391	6480464	Flutamide results in decreased expression of SLCO2B1 mRNA	CTD	PMID:24136188
SLCO2B1	Human	fluvastatin	affects import	EXP		6480464	SLCO2B1 protein affects the import of fluvastatin	CTD	PMID:16046661
SLCO2B1	Human	folic acid	multiple interactions	ISO	RGD:736487	6480464	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLCO2B1 mRNA	CTD	PMID:22206623
SLCO2B1	Human	folpet	decreases expression	ISO	RGD:736487	6480464	folpet results in decreased expression of SLCO2B1 mRNA	CTD	PMID:31558096
SLCO2B1	Human	furan	decreases expression	ISO	RGD:736487	6480464	furan results in decreased expression of SLCO2B1 mRNA	CTD	PMID:24183702
SLCO2B1	Human	furan	decreases expression	ISO	RGD:621391	6480464	furan results in decreased expression of SLCO2B1 mRNA	CTD	PMID:25539665\|PMID:26194646
SLCO2B1	Human	gentamycin	decreases expression	ISO	RGD:621391	6480464	Gentamicins results in decreased expression of SLCO2B1 mRNA	CTD	PMID:22061828
SLCO2B1	Human	glafenine	decreases expression	ISO	RGD:621391	6480464	Glafenine results in decreased expression of SLCO2B1 mRNA	CTD	PMID:24136188
SLCO2B1	Human	glimepiride	multiple interactions	EXP		6480464	glimepiride inhibits the reaction [SLCO2B1 protein results in increased uptake of Atorvastatin]; glimepiride inhibits the more ...	CTD	PMID:23121773
SLCO2B1	Human	glyburide	multiple interactions	EXP		6480464	Glyburide inhibits the reaction [SLCO2B1 protein results in increased uptake of Atorvastatin]	CTD	PMID:23121773
SLCO2B1	Human	Heliotrine	decreases expression	EXP		6480464	heliotrine results in decreased expression of SLCO2B1 mRNA	CTD	PMID:26100227
SLCO2B1	Human	hydrogen peroxide	affects expression	EXP		6480464	Hydrogen Peroxide affects the expression of SLCO2B1 mRNA	CTD	PMID:20044591
SLCO2B1	Human	ibuprofen	decreases expression	EXP		6480464	Ibuprofen results in decreased expression of SLCO2B1 mRNA	CTD	PMID:25596134
SLCO2B1	Human	icariin	decreases activity	EXP		6480464	icariin results in decreased activity of SLCO2B1 protein	CTD	PMID:24265111
SLCO2B1	Human	icariin	multiple interactions	EXP		6480464	[icariin results in decreased activity of SLCO2B1 protein] which results in decreased uptake of estrone more ...	CTD	PMID:24265111
SLCO2B1	Human	imipenem hydrate	multiple interactions	ISO	RGD:736487	6480464	[Vancomycin co-treated with Imipenem] results in increased expression of SLCO2B1 mRNA	CTD	PMID:24657338
SLCO2B1	Human	irinotecan	multiple interactions	EXP		6480464	Irinotecan inhibits the reaction [SLCO2B1 protein results in increased uptake of Cascade Blue]	CTD	PMID:30863990
SLCO2B1	Human	L-ascorbic acid	multiple interactions	EXP		6480464	[[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with more ...	CTD	PMID:34480604
SLCO2B1	Human	L-ascorbic acid 2-phosphate	multiple interactions	EXP		6480464	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA more ...	CTD	PMID:34480604
SLCO2B1	Human	L-methionine	multiple interactions	ISO	RGD:621391	6480464	[Choline deficiency co-treated with Methionine deficiency] results in decreased expression of SLCO2B1 mRNA	CTD	PMID:38663832
SLCO2B1	Human	lidocaine	increases expression	ISO	RGD:621391	6480464	Lidocaine results in increased expression of SLCO2B1 mRNA	CTD	PMID:35283115
SLCO2B1	Human	lipopolysaccharide	increases expression	EXP		6480464	Lipopolysaccharides results in increased expression of SLCO2B1 mRNA; Lipopolysaccharides results in increased expression of SLCO2B1 more ...	CTD	PMID:38423481
SLCO2B1	Human	lipopolysaccharide	decreases expression	EXP		6480464	Lipopolysaccharides results in decreased expression of SLCO2B1 mRNA	CTD	PMID:35811015
SLCO2B1	Human	lipopolysaccharide	multiple interactions	EXP		6480464	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLCO2B1 mRNA; Rifampin more ...	CTD	PMID:35811015\|PMID:38423481
SLCO2B1	Human	Meclizine	increases expression	EXP		6480464	Meclizine results in increased expression of SLCO2B1 mRNA	CTD	PMID:34217791
SLCO2B1	Human	Meclizine	multiple interactions	EXP		6480464	Meclizine promotes the reaction [Ethanol results in increased expression of SLCO2B1 mRNA]	CTD	PMID:34217791
SLCO2B1	Human	mefloquine	multiple interactions	EXP		6480464	Mefloquine affects the reaction [SLCO2B1 protein results in increased uptake of estrone sulfate]	CTD	PMID:27504015
SLCO2B1	Human	mesalamine	multiple interactions	EXP		6480464	Budesonide inhibits the reaction [SLCO2B1 protein results in increased uptake of Mesalamine]; Cyclosporine inhibits the more ...	CTD	PMID:21430235
SLCO2B1	Human	mesalamine	affects uptake	EXP		6480464	SLCO2B1 protein affects the uptake of Mesalamine	CTD	PMID:38844255
SLCO2B1	Human	mesalamine	increases uptake	EXP		6480464	SLCO2B1 protein results in increased uptake of Mesalamine	CTD	PMID:21430235
SLCO2B1	Human	metformin	decreases expression	EXP		6480464	Metformin results in decreased expression of SLCO2B1 mRNA	CTD	PMID:25596134
SLCO2B1	Human	metformin	decreases expression	ISO	RGD:621391	6480464	Metformin results in decreased expression of SLCO2B1 mRNA	CTD	PMID:25596134
SLCO2B1	Human	methamphetamine	decreases expression	ISO	RGD:621391	6480464	Methamphetamine results in decreased expression of SLCO2B1 mRNA	CTD	PMID:19564919
SLCO2B1	Human	methapyrilene	decreases expression	ISO	RGD:621391	6480464	Methapyrilene results in decreased expression of SLCO2B1 mRNA	CTD	PMID:28529062
SLCO2B1	Human	methimazole	decreases expression	ISO	RGD:621391	6480464	Methimazole results in decreased expression of SLCO2B1 mRNA	CTD	PMID:30047161
SLCO2B1	Human	methotrexate	multiple interactions	EXP		6480464	Methotrexate inhibits the reaction [SLCO2B1 protein results in increased uptake of Cascade Blue]	CTD	PMID:30863990
SLCO2B1	Human	metronidazole	increases expression	ISO	RGD:736487	6480464	Metronidazole results in increased expression of SLCO2B1 mRNA	CTD	PMID:24657338
SLCO2B1	Human	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:736487	6480464	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLCO2B1 mRNA	CTD	PMID:36189433
SLCO2B1	Human	nateglinide	multiple interactions	EXP		6480464	Nateglinide inhibits the reaction [SLCO2B1 protein results in increased uptake of Atorvastatin]; Nateglinide inhibits the more ...	CTD	PMID:23121773
SLCO2B1	Human	nitenpyram	increases activity	EXP		6480464	nitenpyram results in increased activity of SLCO2B1 protein	CTD	PMID:31364238
SLCO2B1	Human	O-methyleugenol	decreases expression	EXP		6480464	methyleugenol results in decreased expression of SLCO2B1 mRNA	CTD	PMID:32234424
SLCO2B1	Human	ochratoxin A	increases uptake	EXP		6480464	SLCO2B1 protein results in increased uptake of ochratoxin A	CTD	PMID:28532671
SLCO2B1	Human	okadaic acid	decreases expression	EXP		6480464	Okadaic Acid results in decreased expression of SLCO2B1 mRNA	CTD	PMID:31926150\|PMID:38832940
SLCO2B1	Human	oltipraz	increases expression	ISO	RGD:736487	6480464	oltipraz results in increased expression of SLCO2B1 mRNA	CTD	PMID:15919853
SLCO2B1	Human	ozone	multiple interactions	ISO	RGD:736487	6480464	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased more ...	CTD	PMID:34911549
SLCO2B1	Human	paracetamol	affects expression	ISO	RGD:736487	6480464	Acetaminophen affects the expression of SLCO2B1 mRNA	CTD	PMID:17562736
SLCO2B1	Human	paracetamol	decreases expression	EXP		6480464	Acetaminophen results in decreased expression of SLCO2B1 mRNA	CTD	PMID:29067470
SLCO2B1	Human	PCB138	decreases expression	ISO	RGD:621391	6480464	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SLCO2B1 mRNA	CTD	PMID:23829299
SLCO2B1	Human	perfluorobutanesulfonic acid	increases transport	EXP		6480464	SLCO2B1 protein results in increased transport of perfluorobutanesulfonic acid	CTD	PMID:28013215
SLCO2B1	Human	perfluorobutanesulfonic acid	increases transport	ISO	RGD:621391	6480464	SLCO2B1 protein results in increased transport of perfluorobutanesulfonic acid	CTD	PMID:28013215
SLCO2B1	Human	perfluorodecanoic acid	decreases expression	ISO	RGD:736487	6480464	perfluorodecanoic acid results in decreased expression of SLCO2B1 mRNA	CTD	PMID:38181850
SLCO2B1	Human	perfluorohexanesulfonic acid	increases transport	EXP		6480464	SLCO2B1 protein results in increased transport of perfluorohexanesulfonic acid	CTD	PMID:28013215
SLCO2B1	Human	perfluorohexanesulfonic acid	increases transport	ISO	RGD:621391	6480464	SLCO2B1 protein results in increased transport of perfluorohexanesulfonic acid	CTD	PMID:28013215
SLCO2B1	Human	perfluorononanoic acid	decreases expression	EXP		6480464	perfluoro-n-nonanoic acid results in decreased expression of SLCO2B1 mRNA	CTD	PMID:32588087
SLCO2B1	Human	perfluorooctane-1-sulfonic acid	increases transport	EXP		6480464	SLCO2B1 protein results in increased transport of perfluorooctane sulfonic acid	CTD	PMID:28013215
SLCO2B1	Human	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:736487	6480464	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLCO2B1 mRNA	CTD	PMID:36331819
SLCO2B1	Human	perfluorooctane-1-sulfonic acid	increases transport	ISO	RGD:621391	6480464	SLCO2B1 protein results in increased transport of perfluorooctane sulfonic acid	CTD	PMID:28013215
SLCO2B1	Human	perfluorooctanoic acid	increases expression	ISO	RGD:736487	6480464	perfluorooctanoic acid results in increased expression of SLCO2B1 mRNA	CTD	PMID:38181850
SLCO2B1	Human	phenobarbital	decreases expression	EXP		6480464	Phenobarbital results in decreased expression of SLCO2B1 mRNA	CTD	PMID:16837569
SLCO2B1	Human	phenobarbital	increases expression	EXP		6480464	Phenobarbital results in increased expression of SLCO2B1 protein	CTD	PMID:35881160
SLCO2B1	Human	phenobarbital	increases expression	ISO	RGD:736487	6480464	Phenobarbital results in increased expression of SLCO2B1 protein	CTD	PMID:35881160
SLCO2B1	Human	phenobarbital	affects expression	EXP		6480464	Phenobarbital affects the expression of SLCO2B1 mRNA	CTD	PMID:19159669
SLCO2B1	Human	pioglitazone	multiple interactions	EXP		6480464	pioglitazone affects the reaction [SLCO2B1 protein results in increased uptake of Sulfobromophthalein]	CTD	PMID:23121773
SLCO2B1	Human	pirinixic acid	multiple interactions	ISO	RGD:736487	6480464	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ...	CTD	PMID:19710929
SLCO2B1	Human	pirinixic acid	decreases expression	ISO	RGD:736487	6480464	pirinixic acid results in decreased expression of SLCO2B1 mRNA	CTD	PMID:23811191
SLCO2B1	Human	potassium bromate	affects expression	ISO	RGD:736487	6480464	potassium bromate affects the expression of SLCO2B1 mRNA	CTD	PMID:27082013
SLCO2B1	Human	potassium bromate	multiple interactions	ISO	RGD:736487	6480464	[potassium bromate co-treated with bisphenol A] affects the expression of SLCO2B1 mRNA; [XRCC6 gene mutant more ...	CTD	PMID:27082013
SLCO2B1	Human	potassium dichromate	increases expression	ISO	RGD:736487	6480464	Potassium Dichromate results in increased expression of SLCO2B1 mRNA	CTD	PMID:23608068
SLCO2B1	Human	pravastatin	multiple interactions	EXP		6480464	Pravastatin inhibits the reaction [SLCO2B1 protein results in increased uptake of Mesalamine]; Pravastatin inhibits the more ...	CTD	PMID:21430235
SLCO2B1	Human	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:736487	6480464	Pregnenolone Carbonitrile results in decreased expression of SLCO2B1 mRNA	CTD	PMID:15919853
SLCO2B1	Human	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:621391	6480464	Pregnenolone Carbonitrile results in decreased expression of SLCO2B1 mRNA	CTD	PMID:39069214
SLCO2B1	Human	quercetin	multiple interactions	EXP		6480464	Cyclosporine inhibits the reaction [SLCO2B1 protein results in increased uptake of Quercetin]; estrone sulfate inhibits more ...	CTD	PMID:24947867
SLCO2B1	Human	quercetin	increases uptake	EXP		6480464	SLCO2B1 protein results in increased uptake of Quercetin	CTD	PMID:24947867
SLCO2B1	Human	Repaglinide	multiple interactions	EXP		6480464	repaglinide inhibits the reaction [SLCO2B1 protein results in increased uptake of Atorvastatin]	CTD	PMID:23121773
SLCO2B1	Human	resveratrol	multiple interactions	EXP		6480464	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SLCO2B1 mRNA	CTD	PMID:23557933
SLCO2B1	Human	rifampicin	multiple interactions	EXP		6480464	Rifampin inhibits the reaction [Dextran Sulfate results in increased expression of SLCO2B1 mRNA]; Rifampin inhibits more ...	CTD	PMID:21430235\|PMID:38423481
SLCO2B1	Human	rifampicin	decreases expression	EXP		6480464	Rifampin results in decreased expression of SLCO2B1 mRNA; Rifampin results in decreased expression of SLCO2B1 more ...	CTD	PMID:38423481
SLCO2B1	Human	rifampicin	increases expression	EXP		6480464	Rifampin results in increased expression of SLCO2B1 mRNA	CTD	PMID:27199754
SLCO2B1	Human	rosuvastatin calcium	multiple interactions	EXP		6480464	Rutin promotes the reaction [SLCO2B1 protein results in increased uptake of Rosuvastatin Calcium]	CTD	PMID:24285294
SLCO2B1	Human	rosuvastatin calcium	increases uptake	EXP		6480464	SLCO2B1 protein results in increased uptake of Rosuvastatin Calcium	CTD	PMID:24285294
SLCO2B1	Human	rutin	multiple interactions	EXP		6480464	Rutin promotes the reaction [SLCO2B1 protein results in increased uptake of Cholic Acid]; Rutin promotes more ...	CTD	PMID:24285294
SLCO2B1	Human	rutin	affects localization	EXP		6480464	Rutin affects the localization of SLCO2B1 protein	CTD	PMID:24285294
SLCO2B1	Human	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		6480464	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLCO2B1 mRNA	CTD	PMID:35811015
SLCO2B1	Human	SB 431542	multiple interactions	EXP		6480464	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in more ...	CTD	PMID:34480604
SLCO2B1	Human	Senkirkine	decreases expression	EXP		6480464	senkirkine results in decreased expression of SLCO2B1 mRNA	CTD	PMID:26100227
SLCO2B1	Human	silicon dioxide	decreases expression	ISO	RGD:736487	6480464	Silicon Dioxide results in decreased expression of SLCO2B1 mRNA	CTD	PMID:29203145
SLCO2B1	Human	sodium arsenite	increases expression	EXP		6480464	sodium arsenite results in increased expression of SLCO2B1 mRNA	CTD	PMID:24516582\|PMID:38568856
SLCO2B1	Human	sodium arsenite	decreases expression	EXP		6480464	sodium arsenite results in decreased expression of SLCO2B1 mRNA	CTD	PMID:29301061
SLCO2B1	Human	sodium arsenite	affects methylation	EXP		6480464	sodium arsenite affects the methylation of SLCO2B1 gene	CTD	PMID:28589171
SLCO2B1	Human	sodium arsenite	multiple interactions	ISO	RGD:736487	6480464	[Dietary Fats co-treated with sodium arsenite] results in decreased expression of SLCO2B1 mRNA; [sodium arsenite more ...	CTD	PMID:26890134
SLCO2B1	Human	sodium dichromate	decreases expression	EXP		6480464	sodium bichromate results in decreased expression of SLCO2B1 mRNA	CTD	PMID:17685462
SLCO2B1	Human	sodium dichromate	decreases expression	ISO	RGD:621391	6480464	sodium bichromate results in decreased expression of SLCO2B1 mRNA	CTD	PMID:25993096
SLCO2B1	Human	Soman	increases expression	ISO	RGD:621391	6480464	Soman results in increased expression of SLCO2B1 mRNA	CTD	PMID:19281266
SLCO2B1	Human	spironolactone	decreases expression	ISO	RGD:736487	6480464	Spironolactone results in decreased expression of SLCO2B1 mRNA	CTD	PMID:15919853
SLCO2B1	Human	sulfadimethoxine	decreases expression	ISO	RGD:621391	6480464	Sulfadimethoxine results in decreased expression of SLCO2B1 mRNA	CTD	PMID:30047161
SLCO2B1	Human	tamoxifen	multiple interactions	EXP		6480464	Tamoxifen inhibits the reaction [SLCO2B1 protein results in increased uptake of Cascade Blue]	CTD	PMID:30863990
SLCO2B1	Human	taurocholic acid	multiple interactions	EXP		6480464	Rutin promotes the reaction [SLCO2B1 protein results in increased uptake of Taurocholic Acid]	CTD	PMID:24285294
SLCO2B1	Human	taurocholic acid	increases uptake	EXP		6480464	SLCO2B1 protein results in increased uptake of Taurocholic Acid	CTD	PMID:24285294
SLCO2B1	Human	teniposide	multiple interactions	EXP		6480464	Teniposide inhibits the reaction [SLCO2B1 protein results in increased uptake of Cascade Blue]	CTD	PMID:30863990
SLCO2B1	Human	testosterone	increases expression	ISO	RGD:736487	6480464	Testosterone deficiency results in increased expression of SLCO2B1 mRNA	CTD	PMID:33848595
SLCO2B1	Human	tetrachloroethene	increases expression	ISO	RGD:736487	6480464	Tetrachloroethylene results in increased expression of SLCO2B1 mRNA	CTD	PMID:28973375
SLCO2B1	Human	tetrachloromethane	decreases expression	ISO	RGD:736487	6480464	Carbon Tetrachloride results in decreased expression of SLCO2B1 mRNA	CTD	PMID:27339419\|PMID:31919559
SLCO2B1	Human	tetrachloromethane	multiple interactions	ISO	RGD:621391	6480464	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLCO2B1 mRNA]	CTD	PMID:31150632
SLCO2B1	Human	tetrachloromethane	decreases expression	ISO	RGD:621391	6480464	Carbon Tetrachloride results in decreased expression of SLCO2B1 mRNA	CTD	PMID:31150632
SLCO2B1	Human	tetraphene	increases expression	ISO	RGD:736487	6480464	benz(a)anthracene results in increased expression of SLCO2B1 mRNA	CTD	PMID:26377693
SLCO2B1	Human	Theaflavin 3,3'-digallate	affects expression	EXP		6480464	theaflavin-3,3'-digallate affects the expression of SLCO2B1 mRNA	CTD	PMID:34925699
SLCO2B1	Human	thioacetamide	decreases expression	ISO	RGD:621391	6480464	Thioacetamide results in decreased expression of SLCO2B1 mRNA	CTD	PMID:23411599\|PMID:26222700\|PMID:34492290
SLCO2B1	Human	Thiotepa	multiple interactions	EXP		6480464	Thiotepa inhibits the reaction [SLCO2B1 protein results in increased uptake of Cascade Blue]	CTD	PMID:30863990
SLCO2B1	Human	titanium dioxide	decreases expression	ISO	RGD:736487	6480464	titanium dioxide results in decreased expression of SLCO2B1 mRNA	CTD	PMID:23557971
SLCO2B1	Human	titanium dioxide	multiple interactions	ISO	RGD:736487	6480464	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLCO2B1 more ...	CTD	PMID:29950665
SLCO2B1	Human	topotecan	increases expression	ISO	RGD:621391	6480464	Topotecan results in increased expression of SLCO2B1 mRNA	CTD	PMID:25729387
SLCO2B1	Human	triclosan	increases expression	EXP		6480464	Triclosan results in increased expression of SLCO2B1 mRNA	CTD	PMID:30510588
SLCO2B1	Human	trimellitic anhydride	decreases expression	ISO	RGD:736487	6480464	trimellitic anhydride results in decreased expression of SLCO2B1 mRNA	CTD	PMID:19042947
SLCO2B1	Human	triptonide	increases expression	ISO	RGD:736487	6480464	triptonide results in increased expression of SLCO2B1 mRNA	CTD	PMID:33045310
SLCO2B1	Human	urethane	decreases expression	EXP		6480464	Urethane results in decreased expression of SLCO2B1 mRNA	CTD	PMID:28818685
SLCO2B1	Human	valdecoxib	decreases expression	ISO	RGD:621391	6480464	valdecoxib results in decreased expression of SLCO2B1 mRNA	CTD	PMID:24136188
SLCO2B1	Human	valproic acid	affects expression	ISO	RGD:736487	6480464	Valproic Acid affects the expression of SLCO2B1 mRNA	CTD	PMID:17963808
SLCO2B1	Human	valproic acid	decreases expression	ISO	RGD:621391	6480464	Valproic Acid results in decreased expression of SLCO2B1 mRNA	CTD	PMID:32437819
SLCO2B1	Human	valproic acid	affects expression	EXP		6480464	Valproic Acid affects the expression of SLCO2B1 mRNA	CTD	PMID:25979313
SLCO2B1	Human	vanadium atom	increases expression	EXP		6480464	Vanadium results in increased expression of SLCO2B1 mRNA	CTD	PMID:19000753
SLCO2B1	Human	vanadium(0)	increases expression	EXP		6480464	Vanadium results in increased expression of SLCO2B1 mRNA	CTD	PMID:19000753
SLCO2B1	Human	vancomycin	multiple interactions	ISO	RGD:736487	6480464	[Vancomycin co-treated with Imipenem] results in increased expression of SLCO2B1 mRNA	CTD	PMID:24657338
SLCO2B1	Human	XAV939	multiple interactions	EXP		6480464	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA more ...	CTD	PMID:34480604
SLCO2B1	Human	zearalenone	decreases activity	EXP		6480464	Zearalenone results in decreased activity of SLCO2B1 protein	CTD	PMID:38341109
SLCO2B1	Human	zidovudine	increases expression	EXP		6480464	Zidovudine results in increased expression of SLCO2B1 mRNA	CTD	PMID:24292225
SLCO2B1	Human	zidovudine	decreases expression	EXP		6480464	Zidovudine results in decreased expression of SLCO2B1 mRNA	CTD	PMID:24292225
SLCO2B1	Human	zoledronic acid	increases expression	EXP		6480464	zoledronic acid results in increased expression of SLCO2B1 mRNA	CTD	PMID:24714768\|PMID:25596134

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLCO2B1	Human	bile acid and bile salt transport		ISO	RGD:621391	9068941		RGD	PMID:15345472\|REF_RGD_ID:2316987
SLCO2B1	Human	bile acid and bile salt transport	involved_in	IBA	PANTHER:PTN002604687\|RGD:621391	150520179		GO_Central	GO_REF:0000033
SLCO2B1	Human	cell population proliferation	acts_upstream_of_or_within	ISO	RGD:736487	9068941	PMID:35714613	MGI	PMID:35714613
SLCO2B1	Human	cellular response to iron ion starvation	acts_upstream_of_or_within	ISO	RGD:736487	9068941	PMID:35714613	MGI	PMID:35714613
SLCO2B1	Human	heme catabolic process	involved_in	TAS		150520179		Reactome	Reactome:R-HSA-189483
SLCO2B1	Human	heme import into cell	acts_upstream_of_or_within	ISO	RGD:736487	9068941	PMID:35714613	MGI	PMID:35714613
SLCO2B1	Human	intercellular transport	acts_upstream_of_or_within	ISO	RGD:736487	9068941	PMID:34205780	MGI	PMID:34205780
SLCO2B1	Human	intracellular iron ion homeostasis	acts_upstream_of_or_within	ISO	RGD:736487	9068941	PMID:35714613	MGI	PMID:35714613
SLCO2B1	Human	liver development		ISO	RGD:621391	9068941		RGD	PMID:15345472\|REF_RGD_ID:2316987
SLCO2B1	Human	monoatomic ion transport	involved_in	IEA	UniProtKB-KW:KW-0406	150520179		UniProt	GO_REF:0000043
SLCO2B1	Human	organic anion transport	involved_in	IDA		150520179	PMID:12724351, PMID:22021325	ARUK-UCL	PMID:12724351\|PMID:22021325
SLCO2B1	Human	prostaglandin transport	involved_in	IEA	GO:0015132	150520179		GOC	GO_REF:0000108
SLCO2B1	Human	sodium-independent icosanoid transport		ISO	RGD:621391	9068941		RGD	PMID:15345472\|REF_RGD_ID:2316987
SLCO2B1	Human	sodium-independent organic anion transport	involved_in	TAS		150520179		Reactome	Reactome:R-HSA-879518
SLCO2B1	Human	sodium-independent organic anion transport	involved_in	IBA	PANTHER:PTN002261135\|RGD:621389	150520179		GO_Central	GO_REF:0000033
SLCO2B1	Human	transmembrane transport	involved_in	IDA		150520179	PMID:12724351, PMID:29871943	ARUK-UCL	PMID:12724351\|PMID:29871943
SLCO2B1	Human	transmembrane transport	involved_in	IMP		150520179	PMID:29752999	ARUK-UCL	PMID:29752999
SLCO2B1	Human	transmembrane transport	involved_in	IEA	InterPro:IPR004156	150520179		InterPro	GO_REF:0000002
SLCO2B1	Human	transport across blood-brain barrier	involved_in	NAS		150520179	PMID:26590417, PMID:30280653	ARUK-UCL	PMID:26590417\|PMID:30280653
SLCO2B1	Human	xenobiotic metabolic process	involved_in	TAS		150520179		Reactome	Reactome:R-HSA-9749641\|Reactome:R-HSA-9754706
SLCO2B1	Human	xenobiotic transport	acts_upstream_of_or_within	ISO	RGD:736487	9068941	PMID:34205780	MGI	PMID:34205780

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLCO2B1	Human	apical plasma membrane		ISO	RGD:621391	9068941		RGD	PMID:18619525\|REF_RGD_ID:2301072
SLCO2B1	Human	apical plasma membrane	is_active_in	IBA	PANTHER:PTN002604687\|RGD:621391\|UniProtKB:O94956	150520179		GO_Central	GO_REF:0000033
SLCO2B1	Human	apical plasma membrane	located_in	IEA	UniProtKB-SubCell:SL-0015	150520179		UniProt	GO_REF:0000044
SLCO2B1	Human	apical plasma membrane	located_in	ISS	UniProtKB:Q9JHI3	150520179	PMID:18619525	ARUK-UCL	PMID:18619525
SLCO2B1	Human	apical plasma membrane	located_in	IDA		150520179	PMID:12724351	ARUK-UCL	PMID:12724351
SLCO2B1	Human	basal plasma membrane	located_in	IEA	UniProtKB-SubCell:SL-0024	150520179		UniProt	GO_REF:0000044
SLCO2B1	Human	basal plasma membrane	located_in	IDA		150520179	PMID:11159893, PMID:11932330, PMID:12409283, PMID:12724351, PMID:35307651	UniProt	PMID:11159893\|PMID:11932330\|PMID:12409283\|PMID:12724351\|PMID:35307651
SLCO2B1	Human	basolateral plasma membrane	located_in	IEA	UniProtKB-SubCell:SL-0026	150520179		UniProt	GO_REF:0000044
SLCO2B1	Human	basolateral plasma membrane	is_active_in	IBA	FB:FBgn0032123\|FB:FBgn0034715\|FB:FBgn0034716\|MGI:1351891\|MGI:1889679\|PANTHER:PTN002261135\|RGD:1303048\|RGD:628660\|RGD:69300\|UniProtKB:Q9NYB5	150520179		GO_Central	GO_REF:0000033
SLCO2B1	Human	membrane	located_in	IEA	UniProtKB-SubCell:SL-0162	150520179		UniProt	GO_REF:0000044
SLCO2B1	Human	membrane	located_in	IEA	InterPro:IPR004156	150520179		InterPro	GO_REF:0000002
SLCO2B1	Human	membrane	located_in	IEA	UniProtKB-KW:KW-0472	150520179		UniProt	GO_REF:0000043
SLCO2B1	Human	plasma membrane	located_in	IEA	UniProtKB-SubCell:SL-0039	150520179		UniProt	GO_REF:0000044
SLCO2B1	Human	plasma membrane	is_active_in	ISO	RGD:736487	9068941	PMID:35714613	MGI	PMID:35714613
SLCO2B1	Human	plasma membrane	located_in	IDA		150520179	PMID:21278488, PMID:29752999, PMID:29871943	ARUK-UCL	PMID:21278488\|PMID:29752999\|PMID:29871943
SLCO2B1	Human	plasma membrane	located_in	TAS		150520179		Reactome	Reactome:R-HSA-879562\|Reactome:R-HSA-9661723\|Reactome:R-HSA-9749607\|Reactome:R-HSA-9757010
SLCO2B1	Human	plasma membrane	located_in	IEA	UniProtKB-KW:KW-1003	150520179		UniProt	GO_REF:0000043

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLCO2B1	Human	bile acid transmembrane transporter activity		ISO	RGD:621391	9068941		RGD	PMID:15345472\|REF_RGD_ID:2316987
SLCO2B1	Human	bile acid transmembrane transporter activity	enables	IBA	PANTHER:PTN002604687\|RGD:621391	150520179		GO_Central	GO_REF:0000033
SLCO2B1	Human	organic anion transmembrane transporter activity	enables	IMP		150520179	PMID:29871943	UniProt	PMID:29871943
SLCO2B1	Human	organic anion transmembrane transporter activity	enables	IDA		150520179	PMID:10873595, PMID:11159893, PMID:11932330, PMID:12409283, PMID:12724351, PMID:14610227, PMID:16908597, PMID:18501590, PMID:19129463, PMID:22021325, PMID:22201122, PMID:26383540, PMID:27576593, more ...	UniProt	PMID:10873595\|PMID:11159893\|PMID:11932330\|PMID:12409283\|PMID:12724351\|PMID:14610227\|PMID:16908597\|PMID:18501590\|PMID:19129463\|PMID:22021325\|PMID:22201122\|PMID:26383540\|PMID:27576593\|PMID:34628357
SLCO2B1	Human	prostaglandin transmembrane transporter activity	enables	IDA		150520179	PMID:10873595	UniProt	PMID:10873595
SLCO2B1	Human	sodium-independent organic anion transmembrane transporter activity	enables	TAS		150520179		Reactome	Reactome:R-HSA-879562\|Reactome:R-HSA-9661723\|Reactome:R-HSA-9749607\|Reactome:R-HSA-9757010
SLCO2B1	Human	sodium-independent organic anion transmembrane transporter activity	enables	IBA	PANTHER:PTN002261135\|RGD:621391\|UniProtKB:O94956	150520179		GO_Central	GO_REF:0000033
SLCO2B1	Human	sodium-independent organic anion transmembrane transporter activity	enables	IDA		150520179	PMID:18501590	UniProt	PMID:18501590
SLCO2B1	Human	sodium-independent organic anion transmembrane transporter activity		ISO	RGD:621391	9068941		RGD	PMID:15345472\|REF_RGD_ID:2316987
SLCO2B1	Human	transmembrane transporter activity	enables	IDA		150520179	PMID:25132355	UniProt	PMID:25132355

RGD Manual Annotations

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLCO2B1	Human	statin pharmacokinetics pathway		TAS		2316977		RGD

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLCO2B1	Human	Intellectual disability		IAGP	RGD:42723466	8554872	ClinVar Annotator: match by term: Intellectual disability	ClinVar

#	Reference Title	Reference Citation
1.	GOAs Human GO annotations	GOA_HUMAN data from the GO Consortium
2.	Expression of OATP family members in hormone-related cancers: potential markers of progression.	Pressler H, etal., PLoS One. 2011;6(5):e20372. doi: 10.1371/journal.pone.0020372. Epub 2011 May 19.
3.	ClinVar Automated Import and Annotation Pipeline	RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
4.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions
5.	Pharmacogenetics and pharmacogenomics of cholesterol-lowering therapy.	Schmitz G, etal., Curr Opin Lipidol. 2007 Apr;18(2):164-73.

PMID:8889548	PMID:10048485	PMID:10873595	PMID:11159893	PMID:11932330	PMID:12130747	PMID:12409283	PMID:12477932	PMID:12724351	PMID:14579113	PMID:14610227	PMID:14702039
PMID:15226675	PMID:15489334	PMID:16754786	PMID:16908597	PMID:17906856	PMID:18501590	PMID:18619525	PMID:19129463	PMID:19237515	PMID:19343046	PMID:19383542	PMID:19620935
PMID:19940267	PMID:20159975	PMID:20173083	PMID:20560925	PMID:20635135	PMID:20679960	PMID:20974993	PMID:21266523	PMID:21278488	PMID:21606417	PMID:21780830	PMID:21832049
PMID:21849517	PMID:21873635	PMID:22021325	PMID:22201122	PMID:22822035	PMID:23132664	PMID:23151832	PMID:23190519	PMID:23531488	PMID:23896625	PMID:23970434	PMID:24762081
PMID:24903351	PMID:25132355	PMID:25857231	PMID:26091578	PMID:26383540	PMID:26409184	PMID:26526067	PMID:26590417	PMID:26668348	PMID:26692285	PMID:27576593	PMID:28013215
PMID:28318878	PMID:28493059	PMID:28532671	PMID:28627804	PMID:28815335	PMID:28975866	PMID:29248449	PMID:29422623	PMID:29735582	PMID:29752999	PMID:29871943	PMID:30280653
PMID:30573512	PMID:30587554	PMID:30639242	PMID:31849283	PMID:32114507	PMID:32461666	PMID:32587096	PMID:32602343	PMID:32902299	PMID:33032910	PMID:33723795	PMID:34628357
PMID:34762930	PMID:35307651	PMID:35575683	PMID:35714613	PMID:36253893	PMID:37856781	PMID:38334954	PMID:38423481	PMID:38432624

SLCO2B1
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	11	75,151,107 - 75,206,549 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	11	75,100,563 - 75,206,549 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	11	74,862,152 - 74,917,594 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	11	74,539,811 - 74,594,947 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	11	74,539,810 - 74,594,945	NCBI
Celera	11	72,168,595 - 72,224,004 (+)	NCBI		Celera
Cytogenetic Map	11	q13.4	NCBI
HuRef	11	71,159,611 - 71,215,067 (+)	NCBI		HuRef
CHM1_1	11	74,745,634 - 74,801,048 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	11	75,080,709 - 75,136,155 (+)	NCBI		T2T-CHM13v2.0

Slco2b1
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	7	99,307,011 - 99,360,547 (-)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	7	99,307,011 - 99,360,547 (-)	Ensembl		GRCm39 Ensembl
GRCm38	7	99,657,804 - 99,711,340 (-)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	7	99,657,804 - 99,711,340 (-)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	7	106,806,314 - 106,859,850 (-)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	7	99,531,887 - 99,585,423 (-)	NCBI		MGSCv36	mm8
Celera	7	99,983,704 - 100,037,345 (-)	NCBI		Celera
Cytogenetic Map	7	E1	NCBI
cM Map	7	54.11	NCBI

Slco2b1
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	1	163,371,410 - 163,419,412 (-)	NCBI		GRCr8
mRatBN7.2	1	153,959,288 - 154,007,294 (-)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	1	153,959,293 - 154,007,353 (-)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	1	161,954,894 - 161,991,348 (-)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	1	169,135,025 - 169,171,477 (-)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	1	162,008,573 - 162,045,023 (-)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	1	164,623,313 - 164,671,612 (-)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	1	164,623,599 - 164,671,577 (-)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	1	170,827,265 - 170,875,262 (-)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	1	156,992,492 - 157,028,887 (-)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
RGSC_v3.1	1	157,070,898 - 157,107,293 (-)	NCBI
Celera	1	152,044,550 - 152,080,928 (-)	NCBI		Celera
Cytogenetic Map	1	q32	NCBI

Slco2b1
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955414	16,614,155 - 16,664,485 (-)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955414	16,615,012 - 16,664,784 (-)	NCBI	ChiLan1.0	ChiLan1.0

SLCO2B1
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	9	76,081,750 - 76,137,178 (+)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	11	77,124,430 - 77,179,711 (+)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	11	70,211,124 - 70,266,513 (+)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	11	73,515,433 - 73,570,410 (+)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	11	73,515,433 - 73,570,410 (+)	Ensembl	panpan1.1		panPan2

SLCO2B1
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	21	23,347,593 - 23,393,480 (-)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	21	23,346,070 - 23,473,831 (-)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	21	23,112,620 - 23,158,473 (-)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	21	23,549,950 - 23,595,798 (-)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	21	23,549,950 - 23,595,787 (-)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	21	23,348,431 - 23,394,289 (-)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	21	23,544,699 - 23,590,501 (-)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	21	23,462,533 - 23,508,286 (-)	NCBI		UU_Cfam_GSD_1.0

Slco2b1
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024404947	62,398,940 - 62,447,624 (+)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936498	3,998,474 - 4,047,239 (+)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936498	3,998,537 - 4,047,436 (+)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

SLCO2B1
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	9	9,427,121 - 9,474,230 (+)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	9	9,433,978 - 9,474,248 (+)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	9	10,692,649 - 10,725,453 (-)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

SLCO2B1
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	1	66,375,924 - 66,430,804 (+)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
ChlSab1.1 Ensembl	1	66,376,299 - 66,433,055 (+)	Ensembl	ChlSab1.1	ChlSab1.1 Ensembl	chlSab2
Vero_WHO_p1.0	NW_023666043	59,380,783 - 59,435,113 (-)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Slco2b1
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla_female_1.0 Ensembl	NW_004624817	1,881,327 - 1,931,186 (-)	Ensembl	HetGla_female_1.0	HetGla_female_1.0 Ensembl	hetGla2
HetGla 1.0	NW_004624817	1,879,710 - 1,943,430 (-)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in SLCO2B1
63 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 11q13.4-14.1(chr11:71923251-79662025)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052684]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052684]\|See cases [RCV000052684]	Chr11:71923251..79662025 [GRCh38] Chr11:71634297..79373069 [GRCh37] Chr11:71311945..79050717 [NCBI36] Chr11:11q13.4-14.1	pathogenic
GRCh38/hg38 11q13.4-13.5(chr11:71928796-77064521)x1	copy number loss	See cases [RCV000052708]	Chr11:71928796..77064521 [GRCh38] Chr11:71639842..76751808 [GRCh37] Chr11:71317490..76453216 [NCBI36] Chr11:11q13.4-13.5	pathogenic
GRCh38/hg38 11q13.4-14.1(chr11:71969881-78232895)x1	copy number loss	See cases [RCV000052709]	Chr11:71969881..78232895 [GRCh38] Chr11:71680927..77943941 [GRCh37] Chr11:71358575..77621589 [NCBI36] Chr11:11q13.4-14.1	pathogenic
NM_007256.4(SLCO2B1):c.1780G>T (p.Asp594Tyr)	single nucleotide variant	Malignant melanoma [RCV000069690]	Chr11:75202917 [GRCh38] Chr11:74913962 [GRCh37] Chr11:74591610 [NCBI36] Chr11:11q13.4	not provided
NM_007256.4(SLCO2B1):c.1867G>A (p.Asp623Asn)	single nucleotide variant	Malignant melanoma [RCV000069691]	Chr11:75203345 [GRCh38] Chr11:74914390 [GRCh37] Chr11:74592038 [NCBI36] Chr11:11q13.4	not provided
NM_007256.5(SLCO2B1):c.428G>A (p.Arg143His)	single nucleotide variant	not specified [RCV004282503]	Chr11:75165929 [GRCh38] Chr11:74876974 [GRCh37] Chr11:11q13.4	uncertain significance
GRCh37/hg19 11q13.4(chr11:74580424-75099464)x3	copy number gain	See cases [RCV000448058]	Chr11:74580424..75099464 [GRCh37] Chr11:11q13.4	uncertain significance
GRCh37/hg19 11p15.5-q25(chr11:230616-134938470)	copy number gain	See cases [RCV000511729]	Chr11:230616..134938470 [GRCh37] Chr11:11p15.5-q25	pathogenic
GRCh37/hg19 11p15.5-q25(chr11:230616-134938470)x3	copy number gain	See cases [RCV000510881]	Chr11:230616..134938470 [GRCh37] Chr11:11p15.5-q25	pathogenic
NM_007256.5(SLCO2B1):c.224C>T (p.Thr75Ile)	single nucleotide variant	not specified [RCV004329739]	Chr11:75164039 [GRCh38] Chr11:74875084 [GRCh37] Chr11:11q13.4	uncertain significance
GRCh37/hg19 11q13.4-23.3(chr11:71588805-116680918)x3	copy number gain	not provided [RCV000683374]	Chr11:71588805..116680918 [GRCh37] Chr11:11q13.4-23.3	pathogenic
GRCh37/hg19 11p15.5-q25(chr11:198510-134934063)x3	copy number gain	not provided [RCV000737348]	Chr11:198510..134934063 [GRCh37] Chr11:11p15.5-q25	pathogenic
GRCh37/hg19 11p15.5-q25(chr11:70864-134938470)x3	copy number gain	not provided [RCV000749874]	Chr11:70864..134938470 [GRCh37] Chr11:11p15.5-q25	pathogenic
GRCh37/hg19 11q13.4(chr11:74806005-74949403)x3	copy number gain	not provided [RCV000737585]	Chr11:74806005..74949403 [GRCh37] Chr11:11q13.4	benign
NM_007256.5(SLCO2B1):c.153C>T (p.Phe51=)	single nucleotide variant	not provided [RCV000922242]	Chr11:75163968 [GRCh38] Chr11:74875013 [GRCh37] Chr11:11q13.4	benign
NM_007256.5(SLCO2B1):c.2091G>A (p.Val697=)	single nucleotide variant	not provided [RCV000960113]	Chr11:75204541 [GRCh38] Chr11:74915586 [GRCh37] Chr11:11q13.4	benign
NM_007256.5(SLCO2B1):c.1512C>T (p.Cys504=)	single nucleotide variant	not provided [RCV000905417]	Chr11:75196592 [GRCh38] Chr11:74907637 [GRCh37] Chr11:11q13.4	likely benign
NM_007256.5(SLCO2B1):c.405G>A (p.Pro135=)	single nucleotide variant	not provided [RCV000965208]	Chr11:75165906 [GRCh38] Chr11:74876951 [GRCh37] Chr11:11q13.4	benign
NM_007256.5(SLCO2B1):c.811C>A (p.Arg271=)	single nucleotide variant	not provided [RCV000882377]	Chr11:75172408 [GRCh38] Chr11:74883453 [GRCh37] Chr11:11q13.4	likely benign
NM_007256.5(SLCO2B1):c.712C>T (p.Pro238Ser)	single nucleotide variant	not specified [RCV004326559]	Chr11:75169695 [GRCh38] Chr11:74880740 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.1287C>T (p.Gly429=)	single nucleotide variant	not provided [RCV000963473]	Chr11:75193429 [GRCh38] Chr11:74904474 [GRCh37] Chr11:11q13.4	benign
Single allele	deletion	Intellectual disability [RCV001293382]	Chr11:118359328..118372573 [GRCh37] Chr11:11p15.3-q23.3	pathogenic
GRCh37/hg19 11q13.4-13.5(chr11:74839014-75366449)	copy number gain	not specified [RCV002052937]	Chr11:74839014..75366449 [GRCh37] Chr11:11q13.4-13.5	uncertain significance
NC_000011.9:g.(?_71146421)_(75283128_?)dup	duplication	3-methylglutaconic aciduria, type VIIB [RCV003122786]	Chr11:71146421..75283128 [GRCh37] Chr11:11q13.4-13.5	uncertain significance
NM_007256.5(SLCO2B1):c.1982G>T (p.Gly661Val)	single nucleotide variant	not specified [RCV004683905]	Chr11:75204432 [GRCh38] Chr11:74915477 [GRCh37] Chr11:11q13.4	uncertain significance
GRCh37/hg19 11p13-q25(chr11:32799481-134938470)x3	copy number gain	MISSED ABORTION [RCV002282973]	Chr11:32799481..134938470 [GRCh37] Chr11:11p13-q25	pathogenic
NM_007256.5(SLCO2B1):c.935G>A (p.Arg312Gln)	single nucleotide variant	Atorvastatin response [RCV002291808]	Chr11:75172532 [GRCh38] Chr11:74883577 [GRCh37] Chr11:11q13.4	drug response
NM_007256.5(SLCO2B1):c.892C>G (p.Pro298Ala)	single nucleotide variant	not specified [RCV004328523]	Chr11:75172489 [GRCh38] Chr11:74883534 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.575T>C (p.Met192Thr)	single nucleotide variant	not specified [RCV004079288]	Chr11:75169299 [GRCh38] Chr11:74880344 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.440C>A (p.Thr147Asn)	single nucleotide variant	not specified [RCV004101719]	Chr11:75165941 [GRCh38] Chr11:74876986 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.2077C>G (p.Gln693Glu)	single nucleotide variant	not specified [RCV004186599]	Chr11:75204527 [GRCh38] Chr11:74915572 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.1981G>A (p.Gly661Ser)	single nucleotide variant	not specified [RCV004135506]	Chr11:75204431 [GRCh38] Chr11:74915476 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.303G>C (p.Leu101Phe)	single nucleotide variant	not specified [RCV004169638]	Chr11:75165804 [GRCh38] Chr11:74876849 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.1373T>C (p.Leu458Pro)	single nucleotide variant	not specified [RCV004086091]	Chr11:75193515 [GRCh38] Chr11:74904560 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.1640C>A (p.Pro547His)	single nucleotide variant	not specified [RCV004105221]	Chr11:75200264 [GRCh38] Chr11:74911309 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.353T>C (p.Ile118Thr)	single nucleotide variant	not specified [RCV004241733]	Chr11:75165854 [GRCh38] Chr11:74876899 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.1340T>C (p.Leu447Pro)	single nucleotide variant	not specified [RCV004194150]	Chr11:75193482 [GRCh38] Chr11:74904527 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.1259C>T (p.Ser420Leu)	single nucleotide variant	not specified [RCV004225338]	Chr11:75193401 [GRCh38] Chr11:74904446 [GRCh37] Chr11:11q13.4	likely benign
NM_007256.5(SLCO2B1):c.206T>C (p.Leu69Pro)	single nucleotide variant	not specified [RCV004072896]	Chr11:75164021 [GRCh38] Chr11:74875066 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.559A>C (p.Ser187Arg)	single nucleotide variant	not specified [RCV004162136]	Chr11:75169283 [GRCh38] Chr11:74880328 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.1106G>A (p.Arg369His)	single nucleotide variant	not specified [RCV004215940]	Chr11:75193248 [GRCh38] Chr11:74904293 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.1459C>T (p.Pro487Ser)	single nucleotide variant	not specified [RCV004241432]	Chr11:75196539 [GRCh38] Chr11:74907584 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.1049A>C (p.Asn350Thr)	single nucleotide variant	not specified [RCV004211270]	Chr11:75188212 [GRCh38] Chr11:74899257 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.1013C>T (p.Thr338Met)	single nucleotide variant	not specified [RCV004256295]	Chr11:75188176 [GRCh38] Chr11:74899221 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.29A>T (p.Glu10Val)	single nucleotide variant	not specified [RCV004266115]	Chr11:75162667 [GRCh38] Chr11:74873712 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.749G>A (p.Arg250His)	single nucleotide variant	not specified [RCV004312851]	Chr11:75169732 [GRCh38] Chr11:74880777 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.1267G>A (p.Val423Met)	single nucleotide variant	not specified [RCV004255547]	Chr11:75193409 [GRCh38] Chr11:74904454 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.427C>T (p.Arg143Cys)	single nucleotide variant	not specified [RCV004343046]	Chr11:75165928 [GRCh38] Chr11:74876973 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.1276G>A (p.Val426Met)	single nucleotide variant	not specified [RCV004354356]	Chr11:75193418 [GRCh38] Chr11:74904463 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.370C>T (p.Leu124Phe)	single nucleotide variant	not specified [RCV004348294]	Chr11:75165871 [GRCh38] Chr11:74876916 [GRCh37] Chr11:11q13.4	uncertain significance
GRCh37/hg19 11q12.2-13.5(chr11:59923608-76272324)x3	copy number gain	not provided [RCV003484842]	Chr11:59923608..76272324 [GRCh37] Chr11:11q12.2-13.5	pathogenic
NM_007256.5(SLCO2B1):c.1169T>C (p.Met390Thr)	single nucleotide variant	not specified [RCV004457159]	Chr11:75193311 [GRCh38] Chr11:74904356 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.493A>T (p.Thr165Ser)	single nucleotide variant	not specified [RCV004457166]	Chr11:75169217 [GRCh38] Chr11:74880262 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.686T>A (p.Ile229Asn)	single nucleotide variant	not specified [RCV004457167]	Chr11:75169669 [GRCh38] Chr11:74880714 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.430T>G (p.Tyr144Asp)	single nucleotide variant	not specified [RCV004457165]	Chr11:75165931 [GRCh38] Chr11:74876976 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.1428G>T (p.Gln476His)	single nucleotide variant	not specified [RCV004457163]	Chr11:75193570 [GRCh38] Chr11:74904615 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.1066T>G (p.Phe356Val)	single nucleotide variant	not specified [RCV004457157]	Chr11:75188229 [GRCh38] Chr11:74899274 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.257C>T (p.Thr86Met)	single nucleotide variant	EBV-positive nodal T- and NK-cell lymphoma [RCV004557960]	Chr11:75164072 [GRCh38] Chr11:74875117 [GRCh37] Chr11:11q13.4	likely benign
NM_007256.5(SLCO2B1):c.1112C>G (p.Pro371Arg)	single nucleotide variant	not specified [RCV004457158]	Chr11:75193254 [GRCh38] Chr11:74904299 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.118G>T (p.Val40Leu)	single nucleotide variant	not specified [RCV004457161]	Chr11:75162756 [GRCh38] Chr11:74873801 [GRCh37] Chr11:11q13.4	likely benign
NM_007256.5(SLCO2B1):c.1390G>A (p.Gly464Ser)	single nucleotide variant	not specified [RCV004457162]	Chr11:75193532 [GRCh38] Chr11:74904577 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.359A>G (p.Tyr120Cys)	single nucleotide variant	not specified [RCV004457164]	Chr11:75165860 [GRCh38] Chr11:74876905 [GRCh37] Chr11:11q13.4	likely benign
NM_007256.5(SLCO2B1):c.1936C>G (p.Leu646Val)	single nucleotide variant	not specified [RCV004667416]	Chr11:75203414 [GRCh38] Chr11:74914459 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.916C>T (p.Arg306Cys)	single nucleotide variant	not specified [RCV004667414]	Chr11:75172513 [GRCh38] Chr11:74883558 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.241G>C (p.Gly81Arg)	single nucleotide variant	not specified [RCV004667415]	Chr11:75164056 [GRCh38] Chr11:74875101 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.404C>T (p.Pro135Leu)	single nucleotide variant	not specified [RCV004862465]	Chr11:75165905 [GRCh38] Chr11:74876950 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.491C>A (p.Thr164Lys)	single nucleotide variant	not specified [RCV004862464]	Chr11:75169215 [GRCh38] Chr11:74880260 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.1523C>T (p.Thr508Ile)	single nucleotide variant	not specified [RCV004862468]	Chr11:75196603 [GRCh38] Chr11:74907648 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.868G>C (p.Ala290Pro)	single nucleotide variant	not specified [RCV004862467]	Chr11:75172465 [GRCh38] Chr11:74883510 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.539A>G (p.Tyr180Cys)	single nucleotide variant	not specified [RCV004873011]	Chr11:75169263 [GRCh38] Chr11:74880308 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.1954A>G (p.Ile652Val)	single nucleotide variant	not specified [RCV004873010]	Chr11:75204404 [GRCh38] Chr11:74915449 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.1327G>A (p.Gly443Ser)	single nucleotide variant	not specified [RCV004873012]	Chr11:75193469 [GRCh38] Chr11:74904514 [GRCh37] Chr11:11q13.4	likely benign
NM_007256.5(SLCO2B1):c.631A>G (p.Ile211Val)	single nucleotide variant	not specified [RCV004873015]	Chr11:75169355 [GRCh38] Chr11:74880400 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.748C>T (p.Arg250Cys)	single nucleotide variant	not specified [RCV004457168]	Chr11:75169731 [GRCh38] Chr11:74880776 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.1513G>A (p.Asp505Asn)	single nucleotide variant	not specified [RCV004862466]	Chr11:75196593 [GRCh38] Chr11:74907638 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.121C>T (p.Arg41Trp)	single nucleotide variant	not specified [RCV004873013]	Chr11:75162759 [GRCh38] Chr11:74873804 [GRCh37] Chr11:11q13.4	uncertain significance
NM_007256.5(SLCO2B1):c.1100C>T (p.Thr367Ile)	single nucleotide variant	not specified [RCV004873014]	Chr11:75193242 [GRCh38] Chr11:74904287 [GRCh37] Chr11:11q13.4	uncertain significance

Predicted Target Of

	Summary Value
Count of predictions:	7197
Count of miRNA genes:	1173
Interacting mature miRNAs:	1496
Transcripts:	ENST00000289575, ENST00000341411, ENST00000428359, ENST00000454962, ENST00000525650, ENST00000525845, ENST00000526660, ENST00000526839, ENST00000527180, ENST00000528108, ENST00000530012, ENST00000530015, ENST00000530556, ENST00000531457, ENST00000531713, ENST00000531756, ENST00000532236, ENST00000534004, ENST00000534186
Prediction methods:	Microtar, Miranda, Rnahybrid, Targetscan
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
1357380	BW64_H	Body weight QTL 64 (human)	2.2		Body weight	percent fat after exercise training	11	60978937	86978937	Human

D11S3488

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	11	74,878,704 - 74,878,914	UniSTS	GRCh37
Build 36	11	74,556,352 - 74,556,562	RGD	NCBI36
Celera	11	72,185,258 - 72,185,468	RGD
Cytogenetic Map	11	q13	UniSTS
HuRef	11	71,176,286 - 71,176,496	UniSTS

SHGC-142426

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	11	74,861,156 - 74,861,440	UniSTS	GRCh37
Build 36	11	74,538,804 - 74,539,088	RGD	NCBI36
Celera	11	72,167,711 - 72,167,995	RGD
Cytogenetic Map	11	q13	UniSTS
HuRef	11	71,158,735 - 71,159,019	UniSTS
TNG Radiation Hybrid Map	11	33613.0	UniSTS

SLC21A9_406.2

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	11	74,916,445 - 74,917,344	UniSTS	GRCh37
Build 36	11	74,594,093 - 74,594,992	RGD	NCBI36
Celera	11	72,223,004 - 72,223,903	RGD
HuRef	11	71,214,067 - 71,214,966	UniSTS

STS-T26641

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	11	74,916,926 - 74,917,163	UniSTS	GRCh37
GRCh37	11	74,916,796 - 74,916,925	UniSTS	GRCh37
Build 36	11	74,594,444 - 74,594,573	RGD	NCBI36
Celera	11	72,223,485 - 72,223,722	UniSTS
Celera	11	72,223,355 - 72,223,484	RGD
Cytogenetic Map	11	q13	UniSTS
HuRef	11	71,214,548 - 71,214,785	UniSTS
HuRef	11	71,214,418 - 71,214,547	UniSTS
GeneMap99-GB4 RH Map	11	272.56	UniSTS
NCBI RH Map	11	630.2	UniSTS

D11S1073

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	11	74,915,577 - 74,915,734	UniSTS	GRCh37
Build 36	11	74,593,225 - 74,593,382	RGD	NCBI36
Celera	11	72,222,136 - 72,222,293	RGD
Cytogenetic Map	11	q13	UniSTS
HuRef	11	71,213,199 - 71,213,356	UniSTS

RH45548

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	11	74,895,783 - 74,895,994	UniSTS	GRCh37
Build 36	11	74,573,431 - 74,573,642	RGD	NCBI36
Celera	11	72,202,340 - 72,202,551	RGD
Cytogenetic Map	11	q13	UniSTS
HuRef	11	71,193,368 - 71,193,579	UniSTS
GeneMap99-GB4 RH Map	11	274.08	UniSTS
NCBI RH Map	11	631.8	UniSTS

D8S2278

Human Assembly	Chr	Position (strand)	Source
Cytogenetic Map	5	p15.33	UniSTS
Cytogenetic Map	9	q34.3	UniSTS
Cytogenetic Map	4	q32.1	UniSTS
Cytogenetic Map	6	q22	UniSTS
Cytogenetic Map	15	q15	UniSTS
Cytogenetic Map	17	q25	UniSTS
Cytogenetic Map	19	p12	UniSTS
Cytogenetic Map	22	q13.33	UniSTS
Cytogenetic Map	20	q11.22	UniSTS
Cytogenetic Map	20	q13.12	UniSTS
Cytogenetic Map	19	q13.42	UniSTS
Cytogenetic Map	16	q13	UniSTS
Cytogenetic Map	6	p22.1	UniSTS
Cytogenetic Map	9	q34.11	UniSTS
Cytogenetic Map	13	q14.3	UniSTS
Cytogenetic Map	12	q21.33	UniSTS
Cytogenetic Map	8	p23.1	UniSTS
Cytogenetic Map	14	q24.3	UniSTS
Cytogenetic Map	1	p35.1	UniSTS
Cytogenetic Map	22	q12.2	UniSTS
Cytogenetic Map	16	q24	UniSTS
Cytogenetic Map	22	q13.1	UniSTS
Cytogenetic Map	17	q22	UniSTS
Cytogenetic Map	17	q12	UniSTS
Cytogenetic Map	1	p36.11	UniSTS
Cytogenetic Map	6	q25.3	UniSTS
Cytogenetic Map	1	p34.2	UniSTS
Cytogenetic Map	22	q11.21	UniSTS
Cytogenetic Map	3	p25.3	UniSTS
Cytogenetic Map	3	p25.3-p24.1	UniSTS
Cytogenetic Map	11	q23.3	UniSTS
Cytogenetic Map	12	q24.31	UniSTS
Cytogenetic Map	2	q11.2-q12.1	UniSTS
Cytogenetic Map	20	q13.13	UniSTS
Cytogenetic Map	1	p22	UniSTS
Cytogenetic Map	10	q11	UniSTS
Cytogenetic Map	19	p13.3	UniSTS
Cytogenetic Map	8	p11.21	UniSTS
Cytogenetic Map	17	p13.2	UniSTS
Cytogenetic Map	19	p13.2	UniSTS
Cytogenetic Map	12	q21.31	UniSTS
Cytogenetic Map	2	q33-q34	UniSTS
Cytogenetic Map	22	q12.1	UniSTS
Cytogenetic Map	17	q22.2	UniSTS
Cytogenetic Map	17	p13	UniSTS
Cytogenetic Map	7	q34-q35	UniSTS
Cytogenetic Map	X	p22.1	UniSTS
Cytogenetic Map	1	q23.1	UniSTS
Cytogenetic Map	11	p15.4	UniSTS
Cytogenetic Map	10	q22	UniSTS
Cytogenetic Map	16	q24.3	UniSTS
Cytogenetic Map	10	q23.1	UniSTS
Cytogenetic Map	2	q37	UniSTS
Cytogenetic Map	17	q21	UniSTS
Cytogenetic Map	20	q13.31	UniSTS
Cytogenetic Map	6	p21.33	UniSTS
Cytogenetic Map	5	q35.3	UniSTS
Cytogenetic Map	7	q22.1	UniSTS
Cytogenetic Map	2	q37.1	UniSTS
Cytogenetic Map	17	q21.2	UniSTS
Cytogenetic Map	7	q34	UniSTS
Cytogenetic Map	12	p13.31	UniSTS
Cytogenetic Map	11	q12.3	UniSTS
Cytogenetic Map	4	q34.1	UniSTS
Cytogenetic Map	1	p31.1	UniSTS
Cytogenetic Map	6	q25	UniSTS
Cytogenetic Map	17	q25.3	UniSTS
Cytogenetic Map	3	q21.3	UniSTS
Cytogenetic Map	6	p22	UniSTS
Cytogenetic Map	1	p36.21	UniSTS
Cytogenetic Map	11	p15.5	UniSTS
Cytogenetic Map	4	p14	UniSTS
Cytogenetic Map	8	q24	UniSTS
Cytogenetic Map	2	q11.2	UniSTS
Cytogenetic Map	Y	p11.3	UniSTS
Cytogenetic Map	2	p23.1	UniSTS
Cytogenetic Map	7	q36.3	UniSTS
Cytogenetic Map	19	q13.41	UniSTS
Cytogenetic Map	1	p36.33	UniSTS
Cytogenetic Map	12	p12.3	UniSTS
Cytogenetic Map	5	q32	UniSTS
Cytogenetic Map	8	q24.3	UniSTS
Cytogenetic Map	21	q22.2	UniSTS
Cytogenetic Map	1	q21.2	UniSTS
Cytogenetic Map	15	q22.1	UniSTS
Cytogenetic Map	1	p34-p33	UniSTS
Cytogenetic Map	3	q23	UniSTS
Cytogenetic Map	14	q11.2	UniSTS
Cytogenetic Map	17	q21.1	UniSTS
Cytogenetic Map	6	p21.3	UniSTS
Cytogenetic Map	2	q12.3	UniSTS
Cytogenetic Map	3	q25.31	UniSTS
Cytogenetic Map	14	q22	UniSTS
Cytogenetic Map	19	q13.43	UniSTS
Cytogenetic Map	12	q13.12	UniSTS
Cytogenetic Map	12	p13.3	UniSTS
Cytogenetic Map	5	p12	UniSTS
Cytogenetic Map	19	q13.2	UniSTS
Cytogenetic Map	12	q21.1	UniSTS
Cytogenetic Map	X	p11.23	UniSTS
Cytogenetic Map	17	p11.2	UniSTS
Cytogenetic Map	3	p21.31	UniSTS
Cytogenetic Map	18	p11.21	UniSTS
Cytogenetic Map	3	q26.32	UniSTS
Cytogenetic Map	1	p34.3	UniSTS
Cytogenetic Map	13	q11	UniSTS
Cytogenetic Map	4	p16.3	UniSTS
Cytogenetic Map	17	p12	UniSTS
Cytogenetic Map	17	q11.2	UniSTS
Cytogenetic Map	3	p25.1	UniSTS
Cytogenetic Map	14	q12-q13	UniSTS
Cytogenetic Map	22	q13.2	UniSTS
Cytogenetic Map	17	q11.2-q12	UniSTS
Cytogenetic Map	6	p25	UniSTS
Cytogenetic Map	7	q11.23	UniSTS
Cytogenetic Map	11	p15	UniSTS
Cytogenetic Map	4	q31	UniSTS
Cytogenetic Map	8	p11.22	UniSTS
Cytogenetic Map	7	p22	UniSTS
Cytogenetic Map	15	q15-q21.1	UniSTS
Cytogenetic Map	1	p32-p31	UniSTS
Cytogenetic Map	11	q13	UniSTS
Cytogenetic Map	10	q25.3	UniSTS
Cytogenetic Map	16	p13.3	UniSTS
Cytogenetic Map	10	q24.32	UniSTS
Cytogenetic Map	7	p11.2	UniSTS
Cytogenetic Map	10	q22.3	UniSTS
Cytogenetic Map	6	q27	UniSTS
Cytogenetic Map	11	p15.3	UniSTS
Cytogenetic Map	4	q22.1-q23	UniSTS
Cytogenetic Map	1	q22	UniSTS
Cytogenetic Map	8	p21.3	UniSTS
Cytogenetic Map	17	q22-q23.2	UniSTS
Cytogenetic Map	3	q21	UniSTS
Cytogenetic Map	18	q22.3	UniSTS
Cytogenetic Map	17	p13.3	UniSTS
Cytogenetic Map	6	q22.31	UniSTS
Cytogenetic Map	1	p34.1	UniSTS
Cytogenetic Map	11	q13.1	UniSTS
Cytogenetic Map	X	q26.1	UniSTS
Cytogenetic Map	4	q21.21	UniSTS
Cytogenetic Map	16	q22.2	UniSTS
Cytogenetic Map	X	q13.2	UniSTS
Cytogenetic Map	2	q32.1	UniSTS
Cytogenetic Map	X	p22.33	UniSTS
Cytogenetic Map	Y	p11.32	UniSTS
Cytogenetic Map	10	p13	UniSTS
Cytogenetic Map	X	q22.3	UniSTS
Cytogenetic Map	3	q13.13	UniSTS
Cytogenetic Map	3	q27.3	UniSTS
Cytogenetic Map	10	p11.23	UniSTS
Cytogenetic Map	14	q32.11	UniSTS
Cytogenetic Map	2	q21.1	UniSTS
Cytogenetic Map	15	q25.2	UniSTS
Cytogenetic Map	X	p22.2	UniSTS
Cytogenetic Map	11	q14	UniSTS
Cytogenetic Map	13	q33.1	UniSTS
Cytogenetic Map	19	q13.32	UniSTS
Cytogenetic Map	3	p14.3	UniSTS
Cytogenetic Map	1	p31.3	UniSTS
Cytogenetic Map	1	q31-q41	UniSTS
Cytogenetic Map	2	p16.1	UniSTS
Cytogenetic Map	14	q23	UniSTS
Cytogenetic Map	2	q24.2	UniSTS
Cytogenetic Map	7	q31	UniSTS
Cytogenetic Map	11	q13.4	UniSTS
Cytogenetic Map	12	q12	UniSTS
Cytogenetic Map	11	q12.2	UniSTS
Cytogenetic Map	14	q24.2	UniSTS
Cytogenetic Map	19	q13	UniSTS
Cytogenetic Map	20	q11.22-q11.23	UniSTS
Cytogenetic Map	11	p11.2	UniSTS
Cytogenetic Map	16	p12.2	UniSTS
Cytogenetic Map	17	p13.1	UniSTS
Cytogenetic Map	6	p24.3	UniSTS
Cytogenetic Map	9	p24.1	UniSTS
Cytogenetic Map	12	p13.2	UniSTS
Cytogenetic Map	9	p21	UniSTS
Cytogenetic Map	6	p12.3	UniSTS
Cytogenetic Map	3	p12.1	UniSTS
Cytogenetic Map	1	p13.2	UniSTS
Cytogenetic Map	19	p13.11	UniSTS
Cytogenetic Map	17	q24.1	UniSTS
Cytogenetic Map	15	q13.1	UniSTS
Cytogenetic Map	12	q14.3-q15	UniSTS
Cytogenetic Map	15	q11-q13	UniSTS
Cytogenetic Map	12	q15	UniSTS
Cytogenetic Map	3	q28	UniSTS
Cytogenetic Map	6	p25.2	UniSTS
Cytogenetic Map	2	p14	UniSTS
Cytogenetic Map	2	p21	UniSTS
Cytogenetic Map	14	q24.1	UniSTS
Cytogenetic Map	19	q13.12	UniSTS
Cytogenetic Map	19	q13.4	UniSTS
Cytogenetic Map	2	p11.2	UniSTS
Cytogenetic Map	2	p23.3	UniSTS
Cytogenetic Map	1	q44	UniSTS
Cytogenetic Map	14	q32.2	UniSTS
Cytogenetic Map	14	q12	UniSTS
Cytogenetic Map	13	q32.2	UniSTS
Cytogenetic Map	2	q23.3	UniSTS
Cytogenetic Map	7	p21.1	UniSTS
Cytogenetic Map	8	p12-p11	UniSTS
Cytogenetic Map	1	q25	UniSTS
Cytogenetic Map	3	p21.32	UniSTS
Cytogenetic Map	4	q22.1	UniSTS
Cytogenetic Map	10	q24	UniSTS
Cytogenetic Map	15	q13.3	UniSTS
Cytogenetic Map	7	p15.3	UniSTS
Cytogenetic Map	11	q13.2	UniSTS
Cytogenetic Map	13	q32.3	UniSTS
Cytogenetic Map	11	q24	UniSTS
Cytogenetic Map	X	q25	UniSTS
Cytogenetic Map	12	q24.33	UniSTS
Cytogenetic Map	5	q31.3	UniSTS
Cytogenetic Map	3	q13.2	UniSTS
Cytogenetic Map	3	q25.33	UniSTS
Cytogenetic Map	8	q22.2	UniSTS
Cytogenetic Map	5	q21.2	UniSTS
Cytogenetic Map	5	q15	UniSTS
Cytogenetic Map	3	p26.1	UniSTS
Cytogenetic Map	19	p13.13	UniSTS
Cytogenetic Map	19	q13.13	UniSTS
Cytogenetic Map	19	q13.1	UniSTS
Cytogenetic Map	3	p22-p21.3	UniSTS
Cytogenetic Map	16	p11.2	UniSTS
Cytogenetic Map	20	p11	UniSTS
Cytogenetic Map	2	p12	UniSTS
Cytogenetic Map	7	q21.13	UniSTS
Cytogenetic Map	20	q13.33	UniSTS
Cytogenetic Map	5	q33.1	UniSTS
Cytogenetic Map	3	p21.1-p14.3	UniSTS
Cytogenetic Map	6	p12.1	UniSTS
Cytogenetic Map	7	q36.1	UniSTS
Cytogenetic Map	1	q32.3	UniSTS
Cytogenetic Map	2	p25.1-p24.1	UniSTS
Cytogenetic Map	12	q14.3	UniSTS
Cytogenetic Map	6	q16.1	UniSTS
Cytogenetic Map	5	p13.1	UniSTS
Cytogenetic Map	19	q13.33	UniSTS
Cytogenetic Map	16	p13.2	UniSTS
Cytogenetic Map	12	q13.13	UniSTS
Cytogenetic Map	9	q33.1	UniSTS
Cytogenetic Map	11	q23.1	UniSTS
Cytogenetic Map	21	q22.3	UniSTS
Cytogenetic Map	3	q27.1	UniSTS
Cytogenetic Map	7	q35	UniSTS
Cytogenetic Map	16	p12.3	UniSTS
Cytogenetic Map	2	p25.3	UniSTS
Cytogenetic Map	1	q22-q23	UniSTS
Cytogenetic Map	7	p22.1	UniSTS
Cytogenetic Map	6	q21	UniSTS
Cytogenetic Map	3	p26	UniSTS
Cytogenetic Map	4	q32.3	UniSTS
Cytogenetic Map	3	p14.2	UniSTS
Cytogenetic Map	18	q12.1	UniSTS
Cytogenetic Map	1	p36.3-p36.2	UniSTS
Cytogenetic Map	11	q22-q23	UniSTS
Cytogenetic Map	13	q14.11	UniSTS
Cytogenetic Map	12	p11.21	UniSTS
Cytogenetic Map	8	p21.1	UniSTS
Cytogenetic Map	7	p12.3	UniSTS
Cytogenetic Map	6	p22.3	UniSTS
Cytogenetic Map	17	q23.3	UniSTS
Cytogenetic Map	21	q21.1	UniSTS
Cytogenetic Map	18	q11.2	UniSTS
Cytogenetic Map	18	q21.32	UniSTS
Cytogenetic Map	17	q21.31	UniSTS
Cytogenetic Map	15	q15.1	UniSTS
Cytogenetic Map	14	q22.1	UniSTS
Cytogenetic Map	20	q11.23	UniSTS
Cytogenetic Map	20	p12.1	UniSTS
Cytogenetic Map	5	q31.1	UniSTS
Cytogenetic Map	5	p13.2	UniSTS
Cytogenetic Map	2	q33.2	UniSTS
Cytogenetic Map	2	q33.1	UniSTS
Cytogenetic Map	1	q21.1	UniSTS
Cytogenetic Map	16	q23.1	UniSTS
Cytogenetic Map	12	q23.3	UniSTS
Cytogenetic Map	12	q23.1	UniSTS
Cytogenetic Map	10	q22.2	UniSTS
Cytogenetic Map	1	p22.2	UniSTS
Cytogenetic Map	8	q23.3	UniSTS
Cytogenetic Map	15	q15.3	UniSTS
Cytogenetic Map	2	q12	UniSTS
Cytogenetic Map	11	q25	UniSTS
Cytogenetic Map	X	p21.1	UniSTS
Cytogenetic Map	7	p14.3	UniSTS
Cytogenetic Map	9	q34	UniSTS
Cytogenetic Map	6	p21.31	UniSTS
Cytogenetic Map	5	p15.3	UniSTS
Cytogenetic Map	16	q22.1	UniSTS
Cytogenetic Map	15	q21.2	UniSTS
Cytogenetic Map	10	q21-q22	UniSTS
Cytogenetic Map	17	q25.1	UniSTS
Cytogenetic Map	2	p13.1	UniSTS
Cytogenetic Map	1	q32.1	UniSTS
Cytogenetic Map	17	q24	UniSTS
Cytogenetic Map	1	p33-p32	UniSTS
Cytogenetic Map	7	p13-p11.1	UniSTS
Cytogenetic Map	3	p21.3	UniSTS
Cytogenetic Map	7	q31.3	UniSTS
Cytogenetic Map	X	p22.13	UniSTS
Cytogenetic Map	14	q24	UniSTS
Cytogenetic Map	12	q	UniSTS
Cytogenetic Map	1	p13-p12	UniSTS
Cytogenetic Map	4	q32	UniSTS
Cytogenetic Map	9	q22.33	UniSTS
Cytogenetic Map	4	p16.1	UniSTS
Cytogenetic Map	3	q29	UniSTS
Cytogenetic Map	5	q14.1	UniSTS
Cytogenetic Map	10	q21.1	UniSTS
Cytogenetic Map	X	q28	UniSTS
Cytogenetic Map	1	q23.3	UniSTS
Cytogenetic Map	2	q37.3	UniSTS
Cytogenetic Map	7	p14.1	UniSTS
Cytogenetic Map	2	q22.3	UniSTS
Cytogenetic Map	15	q22.31	UniSTS
Cytogenetic Map	5	q31	UniSTS
Cytogenetic Map	7	q21.11	UniSTS
Cytogenetic Map	2	p25.1	UniSTS
Cytogenetic Map	1	q12	UniSTS
Cytogenetic Map	3	q13.1-q13.2	UniSTS
Cytogenetic Map	11	p13	UniSTS
Cytogenetic Map	14	q32.3	UniSTS
Cytogenetic Map	14	q23.3	UniSTS
Cytogenetic Map	6	p21.1	UniSTS
Cytogenetic Map	1	q24	UniSTS
Cytogenetic Map	1	q43	UniSTS
Cytogenetic Map	19	q13.3	UniSTS
Cytogenetic Map	14	q22.3	UniSTS
Cytogenetic Map	14	q31	UniSTS

D1S3693

Human Assembly	Chr	Position (strand)	Source
Cytogenetic Map	16	q24.3	UniSTS
Cytogenetic Map	22	q13.1	UniSTS
Cytogenetic Map	3	p22	UniSTS
Cytogenetic Map	22	q12.1	UniSTS
Cytogenetic Map	20	q11.21	UniSTS
Cytogenetic Map	21	q22.3	UniSTS
Cytogenetic Map	17	q25.3	UniSTS
Cytogenetic Map	13	q34	UniSTS
Cytogenetic Map	1	q22-q23	UniSTS
Cytogenetic Map	1	p36.21	UniSTS
Cytogenetic Map	19	p13	UniSTS
Cytogenetic Map	8	p21.3	UniSTS
Cytogenetic Map	20	q13.33	UniSTS
Cytogenetic Map	11	q13.2	UniSTS
Cytogenetic Map	12	p13.3	UniSTS
Cytogenetic Map	15	q14	UniSTS
Cytogenetic Map	6	p25.2	UniSTS
Cytogenetic Map	X	p22.33	UniSTS
Cytogenetic Map	Y	p11.32	UniSTS
Cytogenetic Map	10	p15.3-p15.2	UniSTS
Cytogenetic Map	13	q14.13	UniSTS
Cytogenetic Map	17	p13.3	UniSTS
Cytogenetic Map	3	p22.3	UniSTS
Cytogenetic Map	2	q13	UniSTS
Cytogenetic Map	1	q32.3-q41	UniSTS
Cytogenetic Map	1	p13.3	UniSTS
Cytogenetic Map	11	q13.5	UniSTS
Cytogenetic Map	9	q34.11	UniSTS
Cytogenetic Map	1	p36.32	UniSTS
Cytogenetic Map	19	q13.42	UniSTS
Cytogenetic Map	11	q13	UniSTS
Cytogenetic Map	1	q32.1	UniSTS
Cytogenetic Map	22	q13.2	UniSTS
Cytogenetic Map	19	p13.3	UniSTS
Cytogenetic Map	17	q12	UniSTS

D1S1425

Human Assembly	Chr	Position (strand)	Source
Cytogenetic Map	19	q13.3	UniSTS
Cytogenetic Map	1	p33	UniSTS
Cytogenetic Map	17	q11.2	UniSTS
Cytogenetic Map	1	p31.3	UniSTS
Cytogenetic Map	22	q13.1	UniSTS
Cytogenetic Map	9	q34.3	UniSTS
Cytogenetic Map	6	q25.3	UniSTS
Cytogenetic Map	19	p13.12	UniSTS
Cytogenetic Map	1	q32.1	UniSTS
Cytogenetic Map	2	p13.1	UniSTS
Cytogenetic Map	5	q35.3	UniSTS
Cytogenetic Map	2	p11.2	UniSTS
Cytogenetic Map	4	q21.23	UniSTS
Cytogenetic Map	22	q12.1	UniSTS
Cytogenetic Map	8	q24.13	UniSTS
Cytogenetic Map	1	p36.33	UniSTS
Cytogenetic Map	11	q13	UniSTS
Cytogenetic Map	1	q23.1	UniSTS
Cytogenetic Map	10	q22	UniSTS
Cytogenetic Map	4	q12	UniSTS
Cytogenetic Map	10	p14	UniSTS
Cytogenetic Map	6	p21.33	UniSTS
Cytogenetic Map	10	q26.3	UniSTS
Cytogenetic Map	7	q22.1	UniSTS
Cytogenetic Map	19	q13.32	UniSTS
Cytogenetic Map	17	q21.31	UniSTS
Cytogenetic Map	7	p22.2	UniSTS
Cytogenetic Map	12	q13.12	UniSTS
Cytogenetic Map	18	p11.21	UniSTS
Cytogenetic Map	14	q32.12	UniSTS
Cytogenetic Map	2	q31.1	UniSTS
Cytogenetic Map	18	p11.31	UniSTS
Cytogenetic Map	13	q34	UniSTS
Cytogenetic Map	4	p14	UniSTS
Cytogenetic Map	8	p23.1	UniSTS
Cytogenetic Map	4	p16.3	UniSTS
Cytogenetic Map	3	q21.3	UniSTS
Cytogenetic Map	19	p13.2	UniSTS
Cytogenetic Map	8	q12.1	UniSTS
Cytogenetic Map	11	q12.3	UniSTS
Cytogenetic Map	16	p11.2	UniSTS
Cytogenetic Map	10	p12	UniSTS
Cytogenetic Map	12	q13	UniSTS
Cytogenetic Map	11	p15.4	UniSTS
Cytogenetic Map	19	p12	UniSTS
Cytogenetic Map	16	p13.3	UniSTS
Cytogenetic Map	8	q24	UniSTS
Cytogenetic Map	2	p23.3	UniSTS
Cytogenetic Map	5	q13.2	UniSTS
Cytogenetic Map	5	q32	UniSTS
Cytogenetic Map	1	q21.2	UniSTS
Cytogenetic Map	3	q26.2	UniSTS
Cytogenetic Map	6	q25.2-q25.3	UniSTS
Cytogenetic Map	20	q11.2-q13.2	UniSTS
Cytogenetic Map	12	q13.3	UniSTS
Cytogenetic Map	1	q21-q23	UniSTS
Cytogenetic Map	17	q21.32	UniSTS
Cytogenetic Map	1	p35.3	UniSTS
Cytogenetic Map	1	p12	UniSTS
Cytogenetic Map	2	p23-p22	UniSTS
Cytogenetic Map	2	q36.1	UniSTS
Cytogenetic Map	11	q23.3	UniSTS
Cytogenetic Map	2	p16.1	UniSTS
Cytogenetic Map	19	q13.2	UniSTS
Cytogenetic Map	16	q12.1	UniSTS
Cytogenetic Map	17	q22-q23	UniSTS
Cytogenetic Map	2	p11.1	UniSTS
Cytogenetic Map	16	q12.2	UniSTS
Cytogenetic Map	2	p12-p11.2	UniSTS
Cytogenetic Map	3	q11.1	UniSTS
Cytogenetic Map	2	p21	UniSTS
Cytogenetic Map	17	q11.2-q12	UniSTS
Cytogenetic Map	2	q37.1	UniSTS
Cytogenetic Map	1	p32-p31	UniSTS
Cytogenetic Map	1	p21.3	UniSTS
Cytogenetic Map	1	q32.2	UniSTS
Cytogenetic Map	19	q13.1	UniSTS
Cytogenetic Map	7	q21-q22	UniSTS
Cytogenetic Map	1	q25.3	UniSTS
Cytogenetic Map	18	p11.3-p11.2	UniSTS
Cytogenetic Map	2	q33.2	UniSTS
Cytogenetic Map	20	q13.13	UniSTS
Cytogenetic Map	21	p11.1	UniSTS
Cytogenetic Map	12	q24.31-q24.32	UniSTS
Cytogenetic Map	9	q33.2	UniSTS
Cytogenetic Map	11	q13.5	UniSTS
Cytogenetic Map	12	p12.2-p11.2	UniSTS
Cytogenetic Map	21	q22.3	UniSTS
Cytogenetic Map	2	q14.3	UniSTS
Cytogenetic Map	19	p13.3-p13.2	UniSTS
Cytogenetic Map	7	q32.1	UniSTS
Cytogenetic Map	8	p21.3	UniSTS
Cytogenetic Map	17	q22-q23.2	UniSTS
Cytogenetic Map	3	q27.1	UniSTS
Cytogenetic Map	11	q13.1	UniSTS
Cytogenetic Map	4	q21.21	UniSTS
Cytogenetic Map	1	q32	UniSTS
Cytogenetic Map	14	q32	UniSTS
Cytogenetic Map	14	q24.2	UniSTS
Cytogenetic Map	20	q13.33	UniSTS
Cytogenetic Map	3	p21	UniSTS
Cytogenetic Map	10	p11.23	UniSTS
Cytogenetic Map	1	p35.1	UniSTS
Cytogenetic Map	1	q25.2	UniSTS
Cytogenetic Map	18	q12.1	UniSTS
Cytogenetic Map	1	p34.3	UniSTS
Cytogenetic Map	2	q11.2	UniSTS
Cytogenetic Map	15	q23	UniSTS
Cytogenetic Map	8	q24.3	UniSTS
Cytogenetic Map	13	q12.11	UniSTS
Cytogenetic Map	1	p36.31	UniSTS
Cytogenetic Map	3	q21.1	UniSTS
Cytogenetic Map	12	p12	UniSTS
Cytogenetic Map	21	q22.11	UniSTS
Cytogenetic Map	15	q15.3	UniSTS
Cytogenetic Map	X	q12-q13	UniSTS
Cytogenetic Map	22	q11.2	UniSTS
Cytogenetic Map	7	q31.1-q31.3	UniSTS
Cytogenetic Map	X	p22.11	UniSTS
Cytogenetic Map	3	p21.1-p14.2	UniSTS
Cytogenetic Map	2	p24	UniSTS
Cytogenetic Map	20	p12.1	UniSTS
Cytogenetic Map	3	q26.33	UniSTS
Cytogenetic Map	12	q13.11-q14.3	UniSTS
Cytogenetic Map	2	q37.3	UniSTS
Cytogenetic Map	9	q21.33	UniSTS
Cytogenetic Map	12	q12	UniSTS
Cytogenetic Map	X	q13-q21	UniSTS
Cytogenetic Map	8	q24.22	UniSTS
Cytogenetic Map	11	p13	UniSTS
Cytogenetic Map	17	q25.1	UniSTS
Cytogenetic Map	6	q25.2-q27	UniSTS
Cytogenetic Map	12	q24.32	UniSTS
Cytogenetic Map	15	q22.31	UniSTS
Cytogenetic Map	X	q13.1	UniSTS
Cytogenetic Map	22	q12.2	UniSTS
Cytogenetic Map	14	q12	UniSTS
Cytogenetic Map	12	q23-q24.1	UniSTS
Cytogenetic Map	4	q35.1	UniSTS
Cytogenetic Map	17	q24.1	UniSTS
Cytogenetic Map	17	p13.3	UniSTS
Cytogenetic Map	14	q21	UniSTS
Cytogenetic Map	9	p24.3	UniSTS
Cytogenetic Map	7	p13	UniSTS
Cytogenetic Map	2	p14	UniSTS
Cytogenetic Map	21	q22.2	UniSTS
Cytogenetic Map	2	q12.3	UniSTS
Cytogenetic Map	8	p21.1	UniSTS
Cytogenetic Map	17	p13.2	UniSTS
Cytogenetic Map	3	q25.33	UniSTS
Cytogenetic Map	19	q13.12	UniSTS
Cytogenetic Map	5	q31.1	UniSTS
Cytogenetic Map	1	p34	UniSTS
Cytogenetic Map	19	p13.1	UniSTS
Cytogenetic Map	5	q14.1	UniSTS
Cytogenetic Map	X	q22.3	UniSTS
Cytogenetic Map	7	p21.1	UniSTS
Cytogenetic Map	6	p25.2	UniSTS
Cytogenetic Map	10	q23.33	UniSTS
Cytogenetic Map	15	q11-q12	UniSTS
Cytogenetic Map	3	p22.2	UniSTS
Cytogenetic Map	1	p13.3	UniSTS
Cytogenetic Map	15	q21.1-q21.2	UniSTS
Cytogenetic Map	6	p21.3	UniSTS
Cytogenetic Map	7	q34	UniSTS
Cytogenetic Map	4	q13.3	UniSTS
Cytogenetic Map	19	p13.13	UniSTS
Cytogenetic Map	19	q13.41	UniSTS
Cytogenetic Map	17	q24.3	UniSTS
Cytogenetic Map	12	p13.33	UniSTS
Cytogenetic Map	11	q14.1	UniSTS
Cytogenetic Map	3	p22-p21.3	UniSTS
Cytogenetic Map	16	q22.3	UniSTS
Cytogenetic Map	1	p22.1	UniSTS
Cytogenetic Map	6	p12.1	UniSTS
Cytogenetic Map	19	q13.33-q13.41	UniSTS
Cytogenetic Map	2	p25.3	UniSTS
Cytogenetic Map	22	q13.2	UniSTS
Cytogenetic Map	5	p12	UniSTS
Cytogenetic Map	6	q21	UniSTS
Cytogenetic Map	7	q35	UniSTS
Cytogenetic Map	17	p12	UniSTS
Cytogenetic Map	7	q11.1	UniSTS
Cytogenetic Map	2	p25.1-p24.1	UniSTS
Cytogenetic Map	3	q23	UniSTS
Cytogenetic Map	4	q31.21	UniSTS
Cytogenetic Map	5	p13.1	UniSTS
Cytogenetic Map	X	q22.1	UniSTS
Cytogenetic Map	9	q21.11	UniSTS
Cytogenetic Map	5	q13	UniSTS
Cytogenetic Map	1	p22.2	UniSTS
Cytogenetic Map	12	q13.13	UniSTS
Cytogenetic Map	12	q24	UniSTS
Cytogenetic Map	X	q24	UniSTS
Cytogenetic Map	1	q24.2	UniSTS
Cytogenetic Map	22	q13.31	UniSTS
Cytogenetic Map	8	p11.23	UniSTS
Cytogenetic Map	1	q23.3	UniSTS
Cytogenetic Map	16	p12	UniSTS
Cytogenetic Map	10	p15-p14	UniSTS
Cytogenetic Map	19	q13	UniSTS
Cytogenetic Map	1	q22-q23	UniSTS
Cytogenetic Map	20	q11.23	UniSTS
Cytogenetic Map	7	q31	UniSTS
Cytogenetic Map	10	q26	UniSTS
Cytogenetic Map	7	p22.1	UniSTS
Cytogenetic Map	6	p22.3	UniSTS
Cytogenetic Map	6	p21.2	UniSTS
Cytogenetic Map	11	q13.4	UniSTS
Cytogenetic Map	11	q24.2	UniSTS
Cytogenetic Map	X	q28	UniSTS
Cytogenetic Map	1	p33-p32	UniSTS
Cytogenetic Map	5	q35.2	UniSTS
Cytogenetic Map	3	p14.3	UniSTS
Cytogenetic Map	12	q24.33	UniSTS
Cytogenetic Map	3	q26.1-q26.2	UniSTS
Cytogenetic Map	12	p13	UniSTS
Cytogenetic Map	7	q36.1	UniSTS
Cytogenetic Map	8	p11.21	UniSTS
Cytogenetic Map	12	q13.1-q13.2	UniSTS
Cytogenetic Map	1	p36.11	UniSTS
Cytogenetic Map	19	q13.33	UniSTS
Cytogenetic Map	16	p12.3	UniSTS
Cytogenetic Map	13	q14.11	UniSTS
Cytogenetic Map	9	p13.2	UniSTS
Cytogenetic Map	4	q22.1	UniSTS
Cytogenetic Map	3	q13.2	UniSTS
Cytogenetic Map	8	p22	UniSTS
Cytogenetic Map	22	q11.23	UniSTS
Cytogenetic Map	22	q11.21	UniSTS
Cytogenetic Map	1	q42.3	UniSTS
Cytogenetic Map	19	q13.43	UniSTS
Cytogenetic Map	5	q12.3	UniSTS
Cytogenetic Map	20	q11.21	UniSTS
Cytogenetic Map	9	q34.11	UniSTS
Cytogenetic Map	12	q14.3	UniSTS
Cytogenetic Map	6	q15	UniSTS
Cytogenetic Map	6	q22.32	UniSTS
Cytogenetic Map	6	p21.1	UniSTS
Cytogenetic Map	19	q13.31	UniSTS
Cytogenetic Map	16	p13.11	UniSTS
Cytogenetic Map	10	q24.32	UniSTS
Cytogenetic Map	4	p16.1	UniSTS
Cytogenetic Map	18	q11.1	UniSTS
Cytogenetic Map	16	q23.2	UniSTS
Cytogenetic Map	3	q12.1	UniSTS
Cytogenetic Map	15	q24-q25	UniSTS
Cytogenetic Map	7	q31.1	UniSTS
Cytogenetic Map	15	q26.1	UniSTS
Cytogenetic Map	8	q13.1	UniSTS
Cytogenetic Map	6	pter-p12.1	UniSTS
Cytogenetic Map	6	q16	UniSTS
Cytogenetic Map	12	q14.1	UniSTS
Cytogenetic Map	17	q21.2	UniSTS
Cytogenetic Map	9	q22.2	UniSTS
Cytogenetic Map	17	q23.2	UniSTS
Cytogenetic Map	11	q23.1-q23.2	UniSTS
Cytogenetic Map	13	q14	UniSTS
Cytogenetic Map	4	q23	UniSTS
Cytogenetic Map	16	p12.2	UniSTS
Cytogenetic Map	11	q24.3	UniSTS
Cytogenetic Map	7	p14	UniSTS
Cytogenetic Map	15	q24.1	UniSTS
Cytogenetic Map	16	q24.2	UniSTS
Cytogenetic Map	12	q13.11	UniSTS
Cytogenetic Map	9	p13.3	UniSTS
Cytogenetic Map	8	q22.1	UniSTS
Cytogenetic Map	6	q16.2	UniSTS
Cytogenetic Map	5	p15.2	UniSTS
Cytogenetic Map	20	q13.12	UniSTS
Cytogenetic Map	14	q22.3	UniSTS
Cytogenetic Map	2	q13	UniSTS
Cytogenetic Map	3	p21.3	UniSTS
Cytogenetic Map	12	q13.2	UniSTS
Cytogenetic Map	20	p13	UniSTS
Cytogenetic Map	3	q29	UniSTS
Cytogenetic Map	5	q23.3-q31.1	UniSTS
Cytogenetic Map	1	p36	UniSTS
Cytogenetic Map	19	p13.11	UniSTS
Cytogenetic Map	17	q12	UniSTS
Cytogenetic Map	2	q35	UniSTS
Cytogenetic Map	17	p11.2	UniSTS
Cytogenetic Map	1	p34.2	UniSTS
Cytogenetic Map	12	p13.31	UniSTS
Cytogenetic Map	3	q12.3	UniSTS
Cytogenetic Map	11	q23	UniSTS
Cytogenetic Map	12	q24.31	UniSTS
Cytogenetic Map	17	q25.3	UniSTS
Cytogenetic Map	20	q11	UniSTS
Cytogenetic Map	16	q22.1	UniSTS
Cytogenetic Map	5	q23.3	UniSTS
Cytogenetic Map	15	q15.1	UniSTS
Cytogenetic Map	17	q21	UniSTS
Cytogenetic Map	1	q42	UniSTS
Cytogenetic Map	X	p11.23	UniSTS
Cytogenetic Map	12	q24.13	UniSTS
Cytogenetic Map	3	q27.3	UniSTS
Cytogenetic Map	14	q21.3	UniSTS
Cytogenetic Map	19	p13.3	UniSTS
Cytogenetic Map	2	p15	UniSTS
Cytogenetic Map	17	q22	UniSTS
Cytogenetic Map	20	q13.32	UniSTS
Cytogenetic Map	14	q24.3	UniSTS
Cytogenetic Map	X	q21.1	UniSTS

STS-T26641

Human Assembly	Chr	Position (strand)	Source
Cytogenetic Map	11	q13	UniSTS
GeneMap99-GB4 RH Map	11	274.08	UniSTS
NCBI RH Map	11	631.8	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	renal system	reproductive system	respiratory system	sensory system
1204	2408	2788	2231	4818	1713	2233	5	619	1766	462	2169	7087	6280	19	3675	833	1685	1501	166


RefSeq Transcripts	NG_027921	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_001145211	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_001145212	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_007256	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_017017157	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047426333	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047426334	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054367581	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054367582	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054367583	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AB020687	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AB026256	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AF205073	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK127289	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK127363	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK290234	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK294503	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK296079	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK300134	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK302492	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK304783	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL117465	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL833466	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AP001972	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC041095	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC127254	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471076	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CK299190	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068267	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CQ969225	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DC335261	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DC343392	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DC362722	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	FM209049	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	FM209050	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	FM209051	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	FM209052	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	FM209053	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	FM209054	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	GN060121	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	KF455415	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000289575 ⟹ ENSP00000289575

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	75,151,107 - 75,206,549 (+)	Ensembl

Ensembl Acc Id:

ENST00000341411

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	75,203,381 - 75,206,254 (+)	Ensembl

Ensembl Acc Id:

ENST00000428359 ⟹ ENSP00000388912

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	75,159,788 - 75,204,717 (+)	Ensembl

Ensembl Acc Id:

ENST00000454962 ⟹ ENSP00000389653

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	75,151,213 - 75,206,102 (+)	Ensembl

Ensembl Acc Id:

ENST00000525650 ⟹ ENSP00000436324

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	75,151,115 - 75,204,736 (+)	Ensembl

Ensembl Acc Id:

ENST00000525845 ⟹ ENSP00000431324

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	75,159,780 - 75,164,012 (+)	Ensembl

Ensembl Acc Id:

ENST00000526660

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	75,100,563 - 75,188,233 (+)	Ensembl

Ensembl Acc Id:

ENST00000526839 ⟹ ENSP00000434742

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	75,165,874 - 75,170,004 (+)	Ensembl

Ensembl Acc Id:

ENST00000527180 ⟹ ENSP00000436513

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	75,157,071 - 75,169,241 (+)	Ensembl

Ensembl Acc Id:

ENST00000528108

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	75,196,275 - 75,200,400 (+)	Ensembl

Ensembl Acc Id:

ENST00000530012

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	75,196,254 - 75,203,408 (+)	Ensembl

Ensembl Acc Id:

ENST00000530015

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	75,199,554 - 75,206,400 (+)	Ensembl

Ensembl Acc Id:

ENST00000530556 ⟹ ENSP00000435384

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	75,151,788 - 75,164,012 (+)	Ensembl

Ensembl Acc Id:

ENST00000531457

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	75,151,079 - 75,162,923 (+)	Ensembl

Ensembl Acc Id:

ENST00000531713 ⟹ ENSP00000432889

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	75,100,591 - 75,165,830 (+)	Ensembl

Ensembl Acc Id:

ENST00000531756

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	75,151,070 - 75,203,310 (+)	Ensembl

Ensembl Acc Id:

ENST00000532236 ⟹ ENSP00000434112

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	75,151,061 - 75,204,991 (+)	Ensembl

Ensembl Acc Id:

ENST00000534004 ⟹ ENSP00000431192

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	75,152,325 - 75,164,012 (+)	Ensembl

Ensembl Acc Id:

ENST00000534186 ⟹ ENSP00000433872

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	11	75,159,784 - 75,165,948 (+)	Ensembl

RefSeq Acc Id:

NM_001145211 ⟹ NP_001138683

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	75,159,832 - 75,206,549 (+)	NCBI
GRCh37	11	74,862,032 - 74,917,445 (+)	ENTREZGENE
HuRef	11	71,159,611 - 71,215,067 (+)	ENTREZGENE
CHM1_1	11	74,754,446 - 74,801,048 (+)	NCBI
T2T-CHM13v2.0	11	75,089,434 - 75,136,155 (+)	NCBI

Sequence:

show sequence

GGCAGAAAAGGCTGGGATTGAAGCTTCAGGGAGAGCCAGAGGTGAGGCTGGAGTGGGAGATCACCTGAGGCAGGGCCAGCGGGTGAGGTACCCCAGGTACCAGACAAGGAAACCAAAGCCACAATGGG
CACAGAAAACACACCTGGAGGCAAAGCCAGCCCAGACCCTCAGGACGTGCGGCCAAGTGTGTTCCATAACATCAAGCTGTTCGTTCTGTGCCACAGCCTGCTGCAGCTGGCGCAGCTCATGATCTCCG
GCTACCTAAAGAGCTCCATCTCCACAGTGGAGAAGCGCTTCGGCCTCTCCAGCCAGACGTCGGGGCTGCTGGCCTCCTTCAACGAGGTGGGGAACACAGCCTTGATTGTGTTTGTGAGCTATTTTGGC
AGCCGGGTGCACCGACCCCGAATGATTGGCTATGGGGCTATCCTTGTGGCCCTGGCGGGCCTGCTCATGACTCTCCCGCACTTCATCTCGGAGCCATACCGCTACGACAACACCAGCCCTGAGGATAT
GCCACAGGACTTCAAGGCTTCCCTGTGCCTGCCCACAACCTCGGCCCCAGCCTCGGCCCCCTCCAATGGCAACTGCTCAAGCTACACAGAAACCCAGCATCTGAGTGTGGTGGGGATCATGTTCGTGG
CACAGACCCTGCTGGGCGTGGGCGGGGTGCCCATTCAGCCCTTTGGCATCTCCTACATCGATGACTTTGCCCACAACAGCAACTCGCCCCTCTACCTCGGGATCCTGTTTGCAGTGACCATGATGGGG
CCAGGCCTGGCCTTTGGGCTGGGCAGCCTCATGCTGCGCCTTTATGTGGACATTAACCAGATGCCAGAAGGTGGTATCAGCCTGACCATAAAGGACCCCCGATGGGTGGGTGCCTGGTGGCTGGGTTT
CCTCATCGCTGCCGGTGCAGTGGCCCTGGCTGCCATCCCCTACTTCTTCTTCCCCAAGGAAATGCCCAAGGAAAAACGTGAGCTTCAGTTTCGGCGAAAGGTCTTAGCAGTCACAGACTCACCTGCCA
GGAAGGGCAAGGACTCTCCCTCTAAGCAGAGCCCTGGGGAGTCCACGAAGAAGCAGGATGGCCTAGTCCAGATTGCACCAAACCTGACTGTGATCCAGTTCATTAAAGTCTTCCCCAGGGTGCTGCTG
CAGACCCTACGCCACCCCATCTTCCTGCTGGTGGTCCTGTCCCAGGTATGCTTGTCATCCATGGCTGCGGGCATGGCCACCTTCCTGCCCAAGTTCCTGGAGCGCCAGTTTTCCATCACAGCCTCCTA
CGCCAACCTGCTCATCGGCTGCCTCTCCTTCCCTTCGGTCATCGTGGGCATCGTGGTGGGTGGCGTCCTGGTCAAGCGGCTCCACCTGGGCCCTGTGGGATGCGGTGCCCTTTGCCTGCTGGGGATGC
TGCTGTGCCTCTTCTTCAGCCTGCCGCTCTTCTTTATCGGCTGCTCCAGCCACCAGATTGCGGGCATCACACACCAGACCAGTGCCCACCCTGGGCTGGAGCTGTCTCCAAGCTGCATGGAGGCCTGC
TCCTGCCCATTGGACGGCTTTAACCCTGTCTGCGACCCCAGCACTCGTGTGGAATACATCACACCCTGCCACGCAGGCTGCTCAAGCTGGGTGGTCCAGGATGCTCTGGACAACAGCCAGGTTTTCTA
CACCAACTGCAGCTGCGTGGTGGAGGGCAACCCCGTGCTGGCAGGATCCTGCGACTCAACGTGCAGCCATCTGGTGGTGCCCTTCCTGCTCCTGGTCAGCCTGGGCTCGGCCCTGGCCTGTCTCACCC
ACACACCCTCCTTCATGCTCATCCTAAGAGGAGTGAAGAAAGAAGACAAGACTTTGGCTGTGGGCATCCAGTTCATGTTCCTGAGGATTTTGGCCTGGATGCCCAGCCCCGTGATCCACGGCAGCGCC
ATCGACACCACCTGTGTGCACTGGGCCCTGAGCTGTGGGCGTCGAGCTGTCTGTCGCTACTACAATAATGACCTGCTCCGAAACCGGTTCATCGGCCTCCAGTTCTTCTTCAAAACAGGTTCTGTGAT
CTGCTTCGCCTTAGTTTTGGCTGTCCTGAGGCAGCAGGACAAAGAGGCAAGGACCAAAGAGAGCAGATCCAGCCCTGCCGTAGAGCAGCAATTGCTAGTGTCGGGGCCAGGGAAGAAGCCAGAGGATT
CCCGAGTGTGAGCTGTCTTGGGGCCCCACCTGGCCAAGAGTAGCAGCCACAGCAGTACCTCCTCTGAGTCCTTTGCCCAAGATTGGGTGTCAAGAGCCCTGTGTTCCATTCTGGCTCCTCCACTAAAT
TGCTGTGTGACTTCAGGCAAGACATTGATCCTCTCTCAGCCTTTGCTTGCTAGTCTGAACCAAAGAGTTGTTTGGGCATTTGCTGTGTTGGCCATTTCTGGAGCAAGAGGGTCTTCTTCCTCCTTCCC
CCAGCCAGCCAGCTGTCCTGGGGCCAGGCTTTCCTGGGTGGAAAGAAGTATACCTTTCCCTGGGGCCCTAGGATAGCAAAGTGAGCCATAGTGGGCCAGGCTGCCCTCCATGCTGGGCCCCAGCCCAG
GTCTGCACTCGCCTGGATCACCTTCTTTGAGCCTTAGCCATCTCCTGTCAGGTAGGAATGAACTTGCCAGCCTTCAGGCTCGTTCAGCTATGACCATCTGTGCGGTCAGGGTACACTCAGCTCTCCTC
CCCAACTCCAGCAGCCTTTAAGAAGTGTCCCTTTGGCGCCCCCTGGAGGCAGAGCACTGAGCTGGACCCTGGGTAGACTCCCACAGGGAGGACGGAGCTGGCCTCAGGAGTGGGACACCCAGACTTGG
CAGGGCCTTCAAGAGGCCTGTGTGGGGGCCCCAGGAATCCTTAGCTGAAGCGGGGAGACTCACTCTCCATCTCAGGAAATTCTAGCCCTTGCCCTCAGGGAGCCACGGTTGAGGGTGAGGCCCAACAC
CTGCCTTAGGGCCCTGGGTGGGCAAGTCTGGGCCCTGGGGTAGGGAGGGAGACTCAGGCCCACACTTGGGTATTTTCTAATTTCAGACAAACACACACTCAGCGCGCACTCACTGATTCCTACACATT
GCCAAGATTTCACACATGTGACCAGGGGCCACCAAAGTCCCTGTGACCTTTGTGACTAGGATCCTAATTTCTCTATTTTCTCCTGGGTGCCTGGGTCTGTGTCACCTGGGGCAGTGTGGATAATGTTT
AGTTCTGTGACACTGTTTTTTGGGGGTGGCACCTGGTTCTCCGATGCCTGGGCTGGTGTCAGGCCCAGGACTGTAGTGCTGGGAGCAGTAAAGCTCAGCTCTGTGTAATGAGTGATGCTATGGCTTGC
TCGTGTCTTATGATCCAATCCTTTTCTACATCAGCCCTTGTTTTGTTTTATGGCTAGTCTTATCTGGCCTGGTTATTTCCTTGCGGGGAGGAGAGGGTTTGCTAATCTGCTCCCAGCCCAACCTATTA
CCACCCCACCTCGCTGGGACCTACTGCTCGGGAGGCAGCAGACAGGGAGCCACCAGCAGTGGCTTCCTGGCCCTGTGCTGGGGGTGGGGGGAAGCTGGGGGCACATGTGGCCCTTGCCTTCTGAGCAG
CTCCCAGTGCCAGGGCTTTGAGACTTTCCCACATGATAAAAGAAAAGGGAGGTACAGAAGTTCCAATTCCCTTTTTATTTTGCTGGTTGGTATCTGTAAATGTTTAATAAATATCTGAGCATGTATCT
ATCAACGCCAAGAATTTCAAAGTCTCCTTCAACAATATGAGGCTTTTAGGATGTTTATATTCCTTCATCCCTCTTGTTTCCCAGGTTTTGCAGGGAAAAAAAGTCTGGAATTATAGATACAGCTTATT
ATTAAATTTGTTCTTGCATAATGTCTCTTCTATTACAAAAATTCTTTCTTCATAAACTGCATTAGAGGTTTGCAACAACCACATCATTTCCATTAACTTAGATTTAGGTTTTACTGGATTCATTGCTC
ACCATTATTGCTTGTATATTACATCTTTTCCAATCTTTATATTCTGGTCTAATTTTTGTTTGAGTGTCTTCGTCTACTAATGGTTTCAAAAATGGAATAAGGTCATGAGGATTTCTGAATCCTCACCT
GTCCAAATTGTCATTCACATTTTATAGAAGAGGAAACTGGCTCAGAAAGCACAAGTGACT

hide sequence

RefSeq Acc Id:

NM_001145212 ⟹ NP_001138684

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	75,151,107 - 75,206,549 (+)	NCBI
GRCh37	11	74,862,032 - 74,917,445 (+)	ENTREZGENE
HuRef	11	71,159,611 - 71,215,067 (+)	ENTREZGENE
CHM1_1	11	74,745,634 - 74,801,048 (+)	NCBI
T2T-CHM13v2.0	11	75,080,709 - 75,136,155 (+)	NCBI

Sequence:

show sequence

AGAAGGAGCAAGTGACCCAGGGAGACAAACACTTGGAGATACTTGGGGCTGAGTTTGAGCAAGA
CTCCCTAACCTGTGTCTGGACAAGTCTGATGTCCTGTGTGGCCCAAGAAGAACTGACCCCGTGTCTGGAGCTCCCACCGTTATTGCATCCCTGCTGTGGCTCACCTGCTGCTGTCTCCAGGAGCCCCT
GAGAAGATTTGCTTCCTCTCCCCTGCTAAGCTCCAGGTCCTGAGATTAAATTAGGGGCTGGAGCTCACTGCACTCCAGCAGTCATGGGACCCAGGATAGAGGATATGCCACAGGACTTCAAGGCTTCC
CTGTGCCTGCCCACAACCTCGGCCCCAGCCTCGGCCCCCTCCAATGGCAACTGCTCAAGCTACACAGAAACCCAGCATCTGAGTGTGGTGGGGATCATGTTCGTGGCACAGACCCTGCTGGGCGTGGG
CGGGGTGCCCATTCAGCCCTTTGGCATCTCCTACATCGATGACTTTGCCCACAACAGCAACTCGCCCCTCTACCTCGGGATCCTGTTTGCAGTGACCATGATGGGGCCAGGCCTGGCCTTTGGGCTGG
GCAGCCTCATGCTGCGCCTTTATGTGGACATTAACCAGATGCCAGAAGGTGGTATCAGCCTGACCATAAAGGACCCCCGATGGGTGGGTGCCTGGTGGCTGGGTTTCCTCATCGCTGCCGGTGCAGTG
GCCCTGGCTGCCATCCCCTACTTCTTCTTCCCCAAGGAAATGCCCAAGGAAAAACGTGAGCTTCAGTTTCGGCGAAAGGTCTTAGCAGTCACAGACTCACCTGCCAGGAAGGGCAAGGACTCTCCCTC
TAAGCAGAGCCCTGGGGAGTCCACGAAGAAGCAGGATGGCCTAGTCCAGATTGCACCAAACCTGACTGTGATCCAGTTCATTAAAGTCTTCCCCAGGGTGCTGCTGCAGACCCTACGCCACCCCATCT
TCCTGCTGGTGGTCCTGTCCCAGGTATGCTTGTCATCCATGGCTGCGGGCATGGCCACCTTCCTGCCCAAGTTCCTGGAGCGCCAGTTTTCCATCACAGCCTCCTACGCCAACCTGCTCATCGGCTGC
CTCTCCTTCCCTTCGGTCATCGTGGGCATCGTGGTGGGTGGCGTCCTGGTCAAGCGGCTCCACCTGGGCCCTGTGGGATGCGGTGCCCTTTGCCTGCTGGGGATGCTGCTGTGCCTCTTCTTCAGCCT
GCCGCTCTTCTTTATCGGCTGCTCCAGCCACCAGATTGCGGGCATCACACACCAGACCAGTGCCCACCCTGGGCTGGAGCTGTCTCCAAGCTGCATGGAGGCCTGCTCCTGCCCATTGGACGGCTTTA
ACCCTGTCTGCGACCCCAGCACTCGTGTGGAATACATCACACCCTGCCACGCAGGCTGCTCAAGCTGGGTGGTCCAGGATGCTCTGGACAACAGCCAGGTTTTCTACACCAACTGCAGCTGCGTGGTG
GAGGGCAACCCCGTGCTGGCAGGATCCTGCGACTCAACGTGCAGCCATCTGGTGGTGCCCTTCCTGCTCCTGGTCAGCCTGGGCTCGGCCCTGGCCTGTCTCACCCACACACCCTCCTTCATGCTCAT
CCTAAGAGGAGTGAAGAAAGAAGACAAGACTTTGGCTGTGGGCATCCAGTTCATGTTCCTGAGGATTTTGGCCTGGATGCCCAGCCCCGTGATCCACGGCAGCGCCATCGACACCACCTGTGTGCACT
GGGCCCTGAGCTGTGGGCGTCGAGCTGTCTGTCGCTACTACAATAATGACCTGCTCCGAAACCGGTTCATCGGCCTCCAGTTCTTCTTCAAAACAGGTTCTGTGATCTGCTTCGCCTTAGTTTTGGCT
GTCCTGAGGCAGCAGGACAAAGAGGCAAGGACCAAAGAGAGCAGATCCAGCCCTGCCGTAGAGCAGCAATTGCTAGTGTCGGGGCCAGGGAAGAAGCCAGAGGATTCCCGAGTGTGAGCTGTCTTGGG
GCCCCACCTGGCCAAGAGTAGCAGCCACAGCAGTACCTCCTCTGAGTCCTTTGCCCAAGATTGGGTGTCAAGAGCCCTGTGTTCCATTCTGGCTCCTCCACTAAATTGCTGTGTGACTTCAGGCAAGA
CATTGATCCTCTCTCAGCCTTTGCTTGCTAGTCTGAACCAAAGAGTTGTTTGGGCATTTGCTGTGTTGGCCATTTCTGGAGCAAGAGGGTCTTCTTCCTCCTTCCCCCAGCCAGCCAGCTGTCCTGGG
GCCAGGCTTTCCTGGGTGGAAAGAAGTATACCTTTCCCTGGGGCCCTAGGATAGCAAAGTGAGCCATAGTGGGCCAGGCTGCCCTCCATGCTGGGCCCCAGCCCAGGTCTGCACTCGCCTGGATCACC
TTCTTTGAGCCTTAGCCATCTCCTGTCAGGTAGGAATGAACTTGCCAGCCTTCAGGCTCGTTCAGCTATGACCATCTGTGCGGTCAGGGTACACTCAGCTCTCCTCCCCAACTCCAGCAGCCTTTAAG
AAGTGTCCCTTTGGCGCCCCCTGGAGGCAGAGCACTGAGCTGGACCCTGGGTAGACTCCCACAGGGAGGACGGAGCTGGCCTCAGGAGTGGGACACCCAGACTTGGCAGGGCCTTCAAGAGGCCTGTG
TGGGGGCCCCAGGAATCCTTAGCTGAAGCGGGGAGACTCACTCTCCATCTCAGGAAATTCTAGCCCTTGCCCTCAGGGAGCCACGGTTGAGGGTGAGGCCCAACACCTGCCTTAGGGCCCTGGGTGGG
CAAGTCTGGGCCCTGGGGTAGGGAGGGAGACTCAGGCCCACACTTGGGTATTTTCTAATTTCAGACAAACACACACTCAGCGCGCACTCACTGATTCCTACACATTGCCAAGATTTCACACATGTGAC
CAGGGGCCACCAAAGTCCCTGTGACCTTTGTGACTAGGATCCTAATTTCTCTATTTTCTCCTGGGTGCCTGGGTCTGTGTCACCTGGGGCAGTGTGGATAATGTTTAGTTCTGTGACACTGTTTTTTG
GGGGTGGCACCTGGTTCTCCGATGCCTGGGCTGGTGTCAGGCCCAGGACTGTAGTGCTGGGAGCAGTAAAGCTCAGCTCTGTGTAATGAGTGATGCTATGGCTTGCTCGTGTCTTATGATCCAATCCT
TTTCTACATCAGCCCTTGTTTTGTTTTATGGCTAGTCTTATCTGGCCTGGTTATTTCCTTGCGGGGAGGAGAGGGTTTGCTAATCTGCTCCCAGCCCAACCTATTACCACCCCACCTCGCTGGGACCT
ACTGCTCGGGAGGCAGCAGACAGGGAGCCACCAGCAGTGGCTTCCTGGCCCTGTGCTGGGGGTGGGGGGAAGCTGGGGGCACATGTGGCCCTTGCCTTCTGAGCAGCTCCCAGTGCCAGGGCTTTGAG
ACTTTCCCACATGATAAAAGAAAAGGGAGGTACAGAAGTTCCAATTCCCTTTTTATTTTGCTGGTTGGTATCTGTAAATGTTTAATAAATATCTGAGCATGTATCTATCAACGCCAAGAATTTCAAAG
TCTCCTTCAACAATATGAGGCTTTTAGGATGTTTATATTCCTTCATCCCTCTTGTTTCCCAGGTTTTGCAGGGAAAAAAAGTCTGGAATTATAGATACAGCTTATTATTAAATTTGTTCTTGCATAAT
GTCTCTTCTATTACAAAAATTCTTTCTTCATAAACTGCATTAGAGGTTTGCAACAACCACATCATTTCCATTAACTTAGATTTAGGTTTTACTGGATTCATTGCTCACCATTATTGCTTGTATATTAC
ATCTTTTCCAATCTTTATATTCTGGTCTAATTTTTGTTTGAGTGTCTTCGTCTACTAATGGTTTCAAAAATGGAATAAGGTCATGAGGATTTCTGAATCCTCACCTGTCCAAATTGTCATTCACATTT
TATAGAAGAGGAAACTGGCTCAGAAAGCACAAGTGACT

hide sequence

RefSeq Acc Id:

NM_007256 ⟹ NP_009187

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	75,151,107 - 75,206,549 (+)	NCBI
GRCh37	11	74,862,032 - 74,917,445 (+)	ENTREZGENE
Build 36	11	74,539,811 - 74,594,947 (+)	NCBI Archive
HuRef	11	71,159,611 - 71,215,067 (+)	ENTREZGENE
CHM1_1	11	74,745,634 - 74,801,048 (+)	NCBI
T2T-CHM13v2.0	11	75,080,709 - 75,136,155 (+)	NCBI

Sequence:

show sequence

AGAAGGAGCAAGTGACCCAGGGAGACAAACACTTGGAGATACTTGGGGCTGAGTTTGAGCAAGA
CTCCCTAACCTGTGTCTGGACAAGTCTGATGTCCTGTGTGGCCCAAGAAGAACTGACCCCGTGTCTGGAGCTCCCACCGTTATTGCATCCCTGCTGTGGCTCACCTGCTGCTGTCTCCAGGAGCCCCT
GAGAAGATTTGCTTCCTCTCCCCTGCTAAGCTCCAGGTCCTGAGATTAAATTAGGGGCTGGAGCTCACTGCACTCCAGCAGTCATGGGACCCAGGATAGGGCCAGCGGGTGAGGTACCCCAGGTACCA
GACAAGGAAACCAAAGCCACAATGGGCACAGAAAACACACCTGGAGGCAAAGCCAGCCCAGACCCTCAGGACGTGCGGCCAAGTGTGTTCCATAACATCAAGCTGTTCGTTCTGTGCCACAGCCTGCT
GCAGCTGGCGCAGCTCATGATCTCCGGCTACCTAAAGAGCTCCATCTCCACAGTGGAGAAGCGCTTCGGCCTCTCCAGCCAGACGTCGGGGCTGCTGGCCTCCTTCAACGAGGTGGGGAACACAGCCT
TGATTGTGTTTGTGAGCTATTTTGGCAGCCGGGTGCACCGACCCCGAATGATTGGCTATGGGGCTATCCTTGTGGCCCTGGCGGGCCTGCTCATGACTCTCCCGCACTTCATCTCGGAGCCATACCGC
TACGACAACACCAGCCCTGAGGATATGCCACAGGACTTCAAGGCTTCCCTGTGCCTGCCCACAACCTCGGCCCCAGCCTCGGCCCCCTCCAATGGCAACTGCTCAAGCTACACAGAAACCCAGCATCT
GAGTGTGGTGGGGATCATGTTCGTGGCACAGACCCTGCTGGGCGTGGGCGGGGTGCCCATTCAGCCCTTTGGCATCTCCTACATCGATGACTTTGCCCACAACAGCAACTCGCCCCTCTACCTCGGGA
TCCTGTTTGCAGTGACCATGATGGGGCCAGGCCTGGCCTTTGGGCTGGGCAGCCTCATGCTGCGCCTTTATGTGGACATTAACCAGATGCCAGAAGGTGGTATCAGCCTGACCATAAAGGACCCCCGA
TGGGTGGGTGCCTGGTGGCTGGGTTTCCTCATCGCTGCCGGTGCAGTGGCCCTGGCTGCCATCCCCTACTTCTTCTTCCCCAAGGAAATGCCCAAGGAAAAACGTGAGCTTCAGTTTCGGCGAAAGGT
CTTAGCAGTCACAGACTCACCTGCCAGGAAGGGCAAGGACTCTCCCTCTAAGCAGAGCCCTGGGGAGTCCACGAAGAAGCAGGATGGCCTAGTCCAGATTGCACCAAACCTGACTGTGATCCAGTTCA
TTAAAGTCTTCCCCAGGGTGCTGCTGCAGACCCTACGCCACCCCATCTTCCTGCTGGTGGTCCTGTCCCAGGTATGCTTGTCATCCATGGCTGCGGGCATGGCCACCTTCCTGCCCAAGTTCCTGGAG
CGCCAGTTTTCCATCACAGCCTCCTACGCCAACCTGCTCATCGGCTGCCTCTCCTTCCCTTCGGTCATCGTGGGCATCGTGGTGGGTGGCGTCCTGGTCAAGCGGCTCCACCTGGGCCCTGTGGGATG
CGGTGCCCTTTGCCTGCTGGGGATGCTGCTGTGCCTCTTCTTCAGCCTGCCGCTCTTCTTTATCGGCTGCTCCAGCCACCAGATTGCGGGCATCACACACCAGACCAGTGCCCACCCTGGGCTGGAGC
TGTCTCCAAGCTGCATGGAGGCCTGCTCCTGCCCATTGGACGGCTTTAACCCTGTCTGCGACCCCAGCACTCGTGTGGAATACATCACACCCTGCCACGCAGGCTGCTCAAGCTGGGTGGTCCAGGAT
GCTCTGGACAACAGCCAGGTTTTCTACACCAACTGCAGCTGCGTGGTGGAGGGCAACCCCGTGCTGGCAGGATCCTGCGACTCAACGTGCAGCCATCTGGTGGTGCCCTTCCTGCTCCTGGTCAGCCT
GGGCTCGGCCCTGGCCTGTCTCACCCACACACCCTCCTTCATGCTCATCCTAAGAGGAGTGAAGAAAGAAGACAAGACTTTGGCTGTGGGCATCCAGTTCATGTTCCTGAGGATTTTGGCCTGGATGC
CCAGCCCCGTGATCCACGGCAGCGCCATCGACACCACCTGTGTGCACTGGGCCCTGAGCTGTGGGCGTCGAGCTGTCTGTCGCTACTACAATAATGACCTGCTCCGAAACCGGTTCATCGGCCTCCAG
TTCTTCTTCAAAACAGGTTCTGTGATCTGCTTCGCCTTAGTTTTGGCTGTCCTGAGGCAGCAGGACAAAGAGGCAAGGACCAAAGAGAGCAGATCCAGCCCTGCCGTAGAGCAGCAATTGCTAGTGTC
GGGGCCAGGGAAGAAGCCAGAGGATTCCCGAGTGTGAGCTGTCTTGGGGCCCCACCTGGCCAAGAGTAGCAGCCACAGCAGTACCTCCTCTGAGTCCTTTGCCCAAGATTGGGTGTCAAGAGCCCTGT
GTTCCATTCTGGCTCCTCCACTAAATTGCTGTGTGACTTCAGGCAAGACATTGATCCTCTCTCAGCCTTTGCTTGCTAGTCTGAACCAAAGAGTTGTTTGGGCATTTGCTGTGTTGGCCATTTCTGGA
GCAAGAGGGTCTTCTTCCTCCTTCCCCCAGCCAGCCAGCTGTCCTGGGGCCAGGCTTTCCTGGGTGGAAAGAAGTATACCTTTCCCTGGGGCCCTAGGATAGCAAAGTGAGCCATAGTGGGCCAGGCT
GCCCTCCATGCTGGGCCCCAGCCCAGGTCTGCACTCGCCTGGATCACCTTCTTTGAGCCTTAGCCATCTCCTGTCAGGTAGGAATGAACTTGCCAGCCTTCAGGCTCGTTCAGCTATGACCATCTGTG
CGGTCAGGGTACACTCAGCTCTCCTCCCCAACTCCAGCAGCCTTTAAGAAGTGTCCCTTTGGCGCCCCCTGGAGGCAGAGCACTGAGCTGGACCCTGGGTAGACTCCCACAGGGAGGACGGAGCTGGC
CTCAGGAGTGGGACACCCAGACTTGGCAGGGCCTTCAAGAGGCCTGTGTGGGGGCCCCAGGAATCCTTAGCTGAAGCGGGGAGACTCACTCTCCATCTCAGGAAATTCTAGCCCTTGCCCTCAGGGAG
CCACGGTTGAGGGTGAGGCCCAACACCTGCCTTAGGGCCCTGGGTGGGCAAGTCTGGGCCCTGGGGTAGGGAGGGAGACTCAGGCCCACACTTGGGTATTTTCTAATTTCAGACAAACACACACTCAG
CGCGCACTCACTGATTCCTACACATTGCCAAGATTTCACACATGTGACCAGGGGCCACCAAAGTCCCTGTGACCTTTGTGACTAGGATCCTAATTTCTCTATTTTCTCCTGGGTGCCTGGGTCTGTGT
CACCTGGGGCAGTGTGGATAATGTTTAGTTCTGTGACACTGTTTTTTGGGGGTGGCACCTGGTTCTCCGATGCCTGGGCTGGTGTCAGGCCCAGGACTGTAGTGCTGGGAGCAGTAAAGCTCAGCTCT
GTGTAATGAGTGATGCTATGGCTTGCTCGTGTCTTATGATCCAATCCTTTTCTACATCAGCCCTTGTTTTGTTTTATGGCTAGTCTTATCTGGCCTGGTTATTTCCTTGCGGGGAGGAGAGGGTTTGC
TAATCTGCTCCCAGCCCAACCTATTACCACCCCACCTCGCTGGGACCTACTGCTCGGGAGGCAGCAGACAGGGAGCCACCAGCAGTGGCTTCCTGGCCCTGTGCTGGGGGTGGGGGGAAGCTGGGGGC
ACATGTGGCCCTTGCCTTCTGAGCAGCTCCCAGTGCCAGGGCTTTGAGACTTTCCCACATGATAAAAGAAAAGGGAGGTACAGAAGTTCCAATTCCCTTTTTATTTTGCTGGTTGGTATCTGTAAATG
TTTAATAAATATCTGAGCATGTATCTATCAACGCCAAGAATTTCAAAGTCTCCTTCAACAATATGAGGCTTTTAGGATGTTTATATTCCTTCATCCCTCTTGTTTCCCAGGTTTTGCAGGGAAAAAAA
GTCTGGAATTATAGATACAGCTTATTATTAAATTTGTTCTTGCATAATGTCTCTTCTATTACAAAAATTCTTTCTTCATAAACTGCATTAGAGGTTTGCAACAACCACATCATTTCCATTAACTTAGA
TTTAGGTTTTACTGGATTCATTGCTCACCATTATTGCTTGTATATTACATCTTTTCCAATCTTTATATTCTGGTCTAATTTTTGTTTGAGTGTCTTCGTCTACTAATGGTTTCAAAAATGGAATAAGG
TCATGAGGATTTCTGAATCCTCACCTGTCCAAATTGTCATTCACATTTTATAGAAGAGGAAACTGGCTCAGAAAGCACAAGTGACT

hide sequence

RefSeq Acc Id:

XM_017017157 ⟹ XP_016872646

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	75,156,045 - 75,206,549 (+)	NCBI

Sequence:

show sequence

ACTCAAGATGAAGATGGAGATGGAGATGGGGCCAGCGGGTGAGGTACCCCAGGTACCAGACAAGGAAACCAAAGCCACAATGGGCACAGAAAACACACCTGGAGGCAAAGCCAGCCCAGACCCTCAGG
ACGTGCGGCCAAGTGTGTTCCATAACATCAAGCTGTTCGTTCTGTGCCACAGCCTGCTGCAGCTGGCGCAGCTCATGATCTCCGGCTACCTAAAGAGCTCCATCTCCACAGTGGAGAAGCGCTTCGGC
CTCTCCAGCCAGACGTCGGGGCTGCTGGCCTCCTTCAACGAGGTGGGGAACACAGCCTTGATTGTGTTTGTGAGCTATTTTGGCAGCCGGGTGCACCGACCCCGAATGATTGGCTATGGGGCTATCCT
TGTGGCCCTGGCGGGCCTGCTCATGACTCTCCCGCACTTCATCTCGGAGCCATACCGCTACGACAACACCAGCCCTGAGGATATGCCACAGGACTTCAAGGCTTCCCTGTGCCTGCCCACAACCTCGG
CCCCAGCCTCGGCCCCCTCCAATGGCAACTGCTCAAGCTACACAGAAACCCAGCATCTGAGTGTGGTGGGGATCATGTTCGTGGCACAGACCCTGCTGGGCGTGGGCGGGGTGCCCATTCAGCCCTTT
GGCATCTCCTACATCGATGACTTTGCCCACAACAGCAACTCGCCCCTCTACCTCGGGATCCTGTTTGCAGTGACCATGATGGGGCCAGGCCTGGCCTTTGGGCTGGGCAGCCTCATGCTGCGCCTTTA
TGTGGACATTAACCAGATGCCAGAAGGTGGTATCAGCCTGACCATAAAGGACCCCCGATGGGTGGGTGCCTGGTGGCTGGGTTTCCTCATCGCTGCCGGTGCAGTGGCCCTGGCTGCCATCCCCTACT
TCTTCTTCCCCAAGGAAATGCCCAAGGAAAAACGTGAGCTTCAGTTTCGGCGAAAGGTCTTAGCAGTCACAGACTCACCTGCCAGGAAGGGCAAGGACTCTCCCTCTAAGCAGAGCCCTGGGGAGTCC
ACGAAGAAGCAGGATGGCCTAGTCCAGATTGCACCAAACCTGACTGTGATCCAGTTCATTAAAGTCTTCCCCAGGGTGCTGCTGCAGACCCTACGCCACCCCATCTTCCTGCTGGTGGTCCTGTCCCA
GGTATGCTTGTCATCCATGGCTGCGGGCATGGCCACCTTCCTGCCCAAGTTCCTGGAGCGCCAGTTTTCCATCACAGCCTCCTACGCCAACCTGCTCATCGGCTGCCTCTCCTTCCCTTCGGTCATCG
TGGGCATCGTGGTGGGTGGCGTCCTGGTCAAGCGGCTCCACCTGGGCCCTGTGGGATGCGGTGCCCTTTGCCTGCTGGGGATGCTGCTGTGCCTCTTCTTCAGCCTGCCGCTCTTCTTTATCGGCTGC
TCCAGCCACCAGATTGCGGGCATCACACACCAGACCAGTGCCCACCCTGGGCTGGAGCTGTCTCCAAGCTGCATGGAGGCCTGCTCCTGCCCATTGGACGGCTTTAACCCTGTCTGCGACCCCAGCAC
TCGTGTGGAATACATCACACCCTGCCACGCAGGCTGCTCAAGCTGGGTGGTCCAGGATGCTCTGGACAACAGCCAGGTTTTCTACACCAACTGCAGCTGCGTGGTGGAGGGCAACCCCGTGCTGGCAG
GATCCTGCGACTCAACGTGCAGCCATCTGGTGGTGCCCTTCCTGCTCCTGGTCAGCCTGGGCTCGGCCCTGGCCTGTCTCACCCACACACCCTCCTTCATGCTCATCCTAAGAGGAGTGAAGAAAGAA
GACAAGACTTTGGCTGTGGGCATCCAGTTCATGTTCCTGAGGATTTTGGCCTGGATGCCCAGCCCCGTGATCCACGGCAGCGCCATCGACACCACCTGTGTGCACTGGGCCCTGAGCTGTGGGCGTCG
AGCTGTCTGTCGCTACTACAATAATGACCTGCTCCGAAACCGGTTCATCGGCCTCCAGTTCTTCTTCAAAACAGGTTCTGTGATCTGCTTCGCCTTAGTTTTGGCTGTCCTGAGGCAGCAGGACAAAG
AGGCAAGGACCAAAGAGAGCAGATCCAGCCCTGCCGTAGAGCAGCAATTGCTAGTGTCGGGGCCAGGGAAGAAGCCAGAGGATTCCCGAGTGTGAGCTGTCTTGGGGCCCCACCTGGCCAAGAGTAGC
AGCCACAGCAGTACCTCCTCTGAGTCCTTTGCCCAAGATTGGGTGTCAAGAGCCCTGTGTTCCATTCTGGCTCCTCCACTAAATTGCTGTGTGACTTCAGGCAAGACATTGATCCTCTCTCAGCCTTT
GCTTGCTAGTCTGAACCAAAGAGTTGTTTGGGCATTTGCTGTGTTGGCCATTTCTGGAGCAAGAGGGTCTTCTTCCTCCTTCCCCCAGCCAGCCAGCTGTCCTGGGGCCAGGCTTTCCTGGGTGGAAA
GAAGTATACCTTTCCCTGGGGCCCTAGGATAGCAAAGTGAGCCATAGTGGGCCAGGCTGCCCTCCATGCTGGGCCCCAGCCCAGGTCTGCACTCGCCTGGATCACCTTCTTTGAGCCTTAGCCATCTC
CTGTCAGGTAGGAATGAACTTGCCAGCCTTCAGGCTCGTTCAGCTATGACCATCTGTGCGGTCAGGGTACACTCAGCTCTCCTCCCCAACTCCAGCAGCCTTTAAGAAGTGTCCCTTTGGCGCCCCCT
GGAGGCAGAGCACTGAGCTGGACCCTGGGTAGACTCCCACAGGGAGGACGGAGCTGGCCTCAGGAGTGGGACACCCAGACTTGGCAGGGCCTTCAAGAGGCCTGTGTGGGGGCCCCAGGAATCCTTAG
CTGAAGCGGGGAGACTCACTCTCCATCTCAGGAAATTCTAGCCCTTGCCCTCAGGGAGCCACGGTTGAGGGTGAGGCCCAACACCTGCCTTAGGGCCCTGGGTGGGCAAGTCTGGGCCCTGGGGTAGG
GAGGGAGACTCAGGCCCACACTTGGGTATTTTCTAATTTCAGACAAACACACACTCAGCGCGCACTCACTGATTCCTACACATTGCCAAGATTTCACACATGTGACCAGGGGCCACCAAAGTCCCTGT
GACCTTTGTGACTAGGATCCTAATTTCTCTATTTTCTCCTGGGTGCCTGGGTCTGTGTCACCTGGGGCAGTGTGGATAATGTTTAGTTCTGTGACACTGTTTTTTGGGGGTGGCACCTGGTTCTCCGA
TGCCTGGGCTGGTGTCAGGCCCAGGACTGTAGTGCTGGGAGCAGTAAAGCTCAGCTCTGTGTAATGAGTGATGCTATGGCTTGCTCGTGTCTTATGATCCAATCCTTTTCTACATCAGCCCTTGTTTT
GTTTTATGGCTAGTCTTATCTGGCCTGGTTATTTCCTTGCGGGGAGGAGAGGGTTTGCTAATCTGCTCCCAGCCCAACCTATTACCACCCCACCTCGCTGGGACCTACTGCTCGGGAGGCAGCAGACA
GGGAGCCACCAGCAGTGGCTTCCTGGCCCTGTGCTGGGGGTGGGGGGAAGCTGGGGGCACATGTGGCCCTTGCCTTCTGAGCAGCTCCCAGTGCCAGGGCTTTGAGACTTTCCCACATGATAAAAGAA
AAGGGAGGTACAGAAGTTCCAATTCCCTTTTTATTTTGCTGGTTGGTATCTGTAAATGTTTAATAAATATCTGAGCATGTATCTATCAACGCCAAGAATTTCAAAGTCTCCTTCAACAATATGAGGCT
TTTAGGATGTTTATATTCCTTCATCCCTCTTGTTTCCCAGGTTTTGCAGGGAAAAAAAGTCTGGAATTATAGATACAGCTTATTATTAAATTTGTTCTTGCATAATGTCTCTTCTATTACAAAAATTC
TTTCTTCATAAACTGCATTAGAGGTTTGCAACAACCACATCATTTCCATTAACTTAGATTTAGGTTTTACTGGATTCATTGCTCACCATTATTGCTTGTATATTACATCTTTTCCAATCTTTA

hide sequence

RefSeq Acc Id:

XM_047426333 ⟹ XP_047282289

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	75,159,832 - 75,206,549 (+)	NCBI

RefSeq Acc Id:

XM_047426334 ⟹ XP_047282290

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	75,159,832 - 75,206,549 (+)	NCBI

RefSeq Acc Id:

XM_054367581 ⟹ XP_054223556

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	11	75,089,439 - 75,136,155 (+)	NCBI

RefSeq Acc Id:

XM_054367582 ⟹ XP_054223557

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	11	75,089,374 - 75,136,155 (+)	NCBI

RefSeq Acc Id:

XM_054367583 ⟹ XP_054223558

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	11	75,082,095 - 75,136,155 (+)	NCBI


Protein RefSeqs	NP_001138683	(Get FASTA)	NCBI Sequence Viewer
	NP_001138684	(Get FASTA)	NCBI Sequence Viewer
	NP_009187	(Get FASTA)	NCBI Sequence Viewer
	XP_016872646	(Get FASTA)	NCBI Sequence Viewer
	XP_047282289	(Get FASTA)	NCBI Sequence Viewer
	XP_047282290	(Get FASTA)	NCBI Sequence Viewer
	XP_054223556	(Get FASTA)	NCBI Sequence Viewer
	XP_054223557	(Get FASTA)	NCBI Sequence Viewer
	XP_054223558	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAG42205	(Get FASTA)	NCBI Sequence Viewer
	AAH41095	(Get FASTA)	NCBI Sequence Viewer
	BAA74903	(Get FASTA)	NCBI Sequence Viewer
	BAA78638	(Get FASTA)	NCBI Sequence Viewer
	BAF82923	(Get FASTA)	NCBI Sequence Viewer
	BAG57720	(Get FASTA)	NCBI Sequence Viewer
	BAG58835	(Get FASTA)	NCBI Sequence Viewer
	BAG61922	(Get FASTA)	NCBI Sequence Viewer
	BAG63777	(Get FASTA)	NCBI Sequence Viewer
	BAG65535	(Get FASTA)	NCBI Sequence Viewer
	CAB55940	(Get FASTA)	NCBI Sequence Viewer
	CAH56206	(Get FASTA)	NCBI Sequence Viewer
	CAI38409	(Get FASTA)	NCBI Sequence Viewer
	CAR64268	(Get FASTA)	NCBI Sequence Viewer
	CAR64269	(Get FASTA)	NCBI Sequence Viewer
	CAR64270	(Get FASTA)	NCBI Sequence Viewer
	CAR64271	(Get FASTA)	NCBI Sequence Viewer
	CAR64272	(Get FASTA)	NCBI Sequence Viewer
	CAR64273	(Get FASTA)	NCBI Sequence Viewer
	CAX52184	(Get FASTA)	NCBI Sequence Viewer
	EAW74956	(Get FASTA)	NCBI Sequence Viewer
	EAW74957	(Get FASTA)	NCBI Sequence Viewer
	EAW74958	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000289575
	ENSP00000289575.5
	ENSP00000388912
	ENSP00000388912.2
	ENSP00000389653.2
	ENSP00000436324
	ENSP00000436324.1
GenBank Protein	O94956	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:	NP_009187 ⟸ NM_007256
- Peptide Label:	isoform 1
- UniProtKB:	Q9UFU1 (UniProtKB/Swiss-Prot), Q9H2Z0 (UniProtKB/Swiss-Prot), E9PPU8 (UniProtKB/Swiss-Prot), E7ERN5 (UniProtKB/Swiss-Prot), B4DTB0 (UniProtKB/Swiss-Prot), B4DGA9 (UniProtKB/Swiss-Prot), A8K2G9 (UniProtKB/Swiss-Prot), O94956 (UniProtKB/Swiss-Prot), A0A024R5I4 (UniProtKB/TrEMBL), E9PRW4 (UniProtKB/TrEMBL)
- Sequence:	show sequence MGPRIGPAGEVPQVPDKETKATMGTENTPGGKASPDPQDVRPSVFHNIKLFVLCHSLLQLAQLMISGYLKSSISTVEKRFGLSSQTSGLLASFNEVGNTALIVFVSYFGSRVHRPRMIGYGAILVALA GLLMTLPHFISEPYRYDNTSPEDMPQDFKASLCLPTTSAPASAPSNGNCSSYTETQHLSVVGIMFVAQTLLGVGGVPIQPFGISYIDDFAHNSNSPLYLGILFAVTMMGPGLAFGLGSLMLRLYVDIN QMPEGGISLTIKDPRWVGAWWLGFLIAAGAVALAAIPYFFFPKEMPKEKRELQFRRKVLAVTDSPARKGKDSPSKQSPGESTKKQDGLVQIAPNLTVIQFIKVFPRVLLQTLRHPIFLLVVLSQVCLS SMAAGMATFLPKFLERQFSITASYANLLIGCLSFPSVIVGIVVGGVLVKRLHLGPVGCGALCLLGMLLCLFFSLPLFFIGCSSHQIAGITHQTSAHPGLELSPSCMEACSCPLDGFNPVCDPSTRVEY ITPCHAGCSSWVVQDALDNSQVFYTNCSCVVEGNPVLAGSCDSTCSHLVVPFLLLVSLGSALACLTHTPSFMLILRGVKKEDKTLAVGIQFMFLRILAWMPSPVIHGSAIDTTCVHWALSCGRRAVCR YYNNDLLRNRFIGLQFFFKTGSVICFALVLAVLRQQDKEARTKESRSSPAVEQQLLVSGPGKKPEDSRV hide sequence

RefSeq Acc Id:	NP_001138684 ⟸ NM_001145212
- Peptide Label:	isoform 3
- UniProtKB:	A0A0A0MTF1 (UniProtKB/TrEMBL), E9PRW4 (UniProtKB/TrEMBL)
- Sequence:	show sequence MGPRIEDMPQDFKASLCLPTTSAPASAPSNGNCSSYTETQHLSVVGIMFVAQTLLGVGGVPIQPFGISYIDDFAHNSNSPLYLGILFAVTMMGPGLAFGLGSLMLRLYVDINQMPEGGISLTIKDPRW VGAWWLGFLIAAGAVALAAIPYFFFPKEMPKEKRELQFRRKVLAVTDSPARKGKDSPSKQSPGESTKKQDGLVQIAPNLTVIQFIKVFPRVLLQTLRHPIFLLVVLSQVCLSSMAAGMATFLPKFLER QFSITASYANLLIGCLSFPSVIVGIVVGGVLVKRLHLGPVGCGALCLLGMLLCLFFSLPLFFIGCSSHQIAGITHQTSAHPGLELSPSCMEACSCPLDGFNPVCDPSTRVEYITPCHAGCSSWVVQDA LDNSQVFYTNCSCVVEGNPVLAGSCDSTCSHLVVPFLLLVSLGSALACLTHTPSFMLILRGVKKEDKTLAVGIQFMFLRILAWMPSPVIHGSAIDTTCVHWALSCGRRAVCRYYNNDLLRNRFIGLQF FFKTGSVICFALVLAVLRQQDKEARTKESRSSPAVEQQLLVSGPGKKPEDSRV hide sequence

RefSeq Acc Id:	NP_001138683 ⟸ NM_001145211
- Peptide Label:	isoform 2
- UniProtKB:	E9PRW4 (UniProtKB/TrEMBL)
- Sequence:	show sequence MGTENTPGGKASPDPQDVRPSVFHNIKLFVLCHSLLQLAQLMISGYLKSSISTVEKRFGLSSQT SGLLASFNEVGNTALIVFVSYFGSRVHRPRMIGYGAILVALAGLLMTLPHFISEPYRYDNTSPEDMPQDFKASLCLPTTSAPASAPSNGNCSSYTETQHLSVVGIMFVAQTLLGVGGVPIQPFGISYI DDFAHNSNSPLYLGILFAVTMMGPGLAFGLGSLMLRLYVDINQMPEGGISLTIKDPRWVGAWWLGFLIAAGAVALAAIPYFFFPKEMPKEKRELQFRRKVLAVTDSPARKGKDSPSKQSPGESTKKQD GLVQIAPNLTVIQFIKVFPRVLLQTLRHPIFLLVVLSQVCLSSMAAGMATFLPKFLERQFSITASYANLLIGCLSFPSVIVGIVVGGVLVKRLHLGPVGCGALCLLGMLLCLFFSLPLFFIGCSSHQI AGITHQTSAHPGLELSPSCMEACSCPLDGFNPVCDPSTRVEYITPCHAGCSSWVVQDALDNSQVFYTNCSCVVEGNPVLAGSCDSTCSHLVVPFLLLVSLGSALACLTHTPSFMLILRGVKKEDKTLA VGIQFMFLRILAWMPSPVIHGSAIDTTCVHWALSCGRRAVCRYYNNDLLRNRFIGLQFFFKTGSVICFALVLAVLRQQDKEARTKESRSSPAVEQQLLVSGPGKKPEDSRV hide sequence

RefSeq Acc Id:	XP_016872646 ⟸ XM_017017157
- Peptide Label:	isoform X1
- UniProtKB:	E9PRW4 (UniProtKB/TrEMBL)
- Sequence:	show sequence MKMEMEMGPAGEVPQVPDKETKATMGTENTPGGKASPDPQDVRPSVFHNIKLFVLCHSLLQLAQLMISGYLKSSISTVEKRFGLSSQTSGLLASFNEVGNTALIVFVSYFGSRVHRPRMIGYGAILVA LAGLLMTLPHFISEPYRYDNTSPEDMPQDFKASLCLPTTSAPASAPSNGNCSSYTETQHLSVVGIMFVAQTLLGVGGVPIQPFGISYIDDFAHNSNSPLYLGILFAVTMMGPGLAFGLGSLMLRLYVD INQMPEGGISLTIKDPRWVGAWWLGFLIAAGAVALAAIPYFFFPKEMPKEKRELQFRRKVLAVTDSPARKGKDSPSKQSPGESTKKQDGLVQIAPNLTVIQFIKVFPRVLLQTLRHPIFLLVVLSQVC LSSMAAGMATFLPKFLERQFSITASYANLLIGCLSFPSVIVGIVVGGVLVKRLHLGPVGCGALCLLGMLLCLFFSLPLFFIGCSSHQIAGITHQTSAHPGLELSPSCMEACSCPLDGFNPVCDPSTRV EYITPCHAGCSSWVVQDALDNSQVFYTNCSCVVEGNPVLAGSCDSTCSHLVVPFLLLVSLGSALACLTHTPSFMLILRGVKKEDKTLAVGIQFMFLRILAWMPSPVIHGSAIDTTCVHWALSCGRRAV CRYYNNDLLRNRFIGLQFFFKTGSVICFALVLAVLRQQDKEARTKESRSSPAVEQQLLVSGPGKKPEDSRV hide sequence

Ensembl Acc Id:

ENSP00000435384 ⟸ ENST00000530556

Protein Domains

Kazal-like

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-O94956-F1-model_v2	AlphaFold	O94956	1-709	view protein structure

RGD ID:

7221559

Promoter ID:

EPDNEW_H16525

Type:

initiation region

Name:

SLCO2B1_1

Description:

solute carrier organic anion transporter family member 2B1

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H16524 EPDNEW_H16526

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	75,151,107 - 75,151,167	EPDNEW

RGD ID:

7221561

Promoter ID:

EPDNEW_H16526

Type:

initiation region

Name:

SLCO2B1_3

Description:

solute carrier organic anion transporter family member 2B1

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H16524 EPDNEW_H16525

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	11	75,159,832 - 75,159,892	EPDNEW

Database	Acc Id	Source(s)
COSMIC	SLCO2B1	COSMIC
Ensembl Genes	ENSG00000137491	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000289575	ENTREZGENE
	ENST00000289575.10	UniProtKB/Swiss-Prot
	ENST00000428359	ENTREZGENE
	ENST00000428359.6	UniProtKB/Swiss-Prot
	ENST00000454962.6	UniProtKB/Swiss-Prot
	ENST00000525650	ENTREZGENE
	ENST00000525650.5	UniProtKB/Swiss-Prot
Gene3D-CATH	1.20.1250.20	UniProtKB/Swiss-Prot
GTEx	ENSG00000137491	GTEx
HGNC ID	HGNC:10962	ENTREZGENE
Human Proteome Map	SLCO2B1	Human Proteome Map
InterPro	Kazal_dom	UniProtKB/Swiss-Prot
	MFS_trans_sf	UniProtKB/Swiss-Prot
	OATP	UniProtKB/Swiss-Prot
KEGG Report	hsa:11309	UniProtKB/Swiss-Prot
NCBI Gene	11309	ENTREZGENE
OMIM	604988	OMIM
PANTHER	PTHR11388	UniProtKB/Swiss-Prot
	SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY MEMBER 2B1	UniProtKB/Swiss-Prot
Pfam	OATP	UniProtKB/Swiss-Prot
PharmGKB	PA35845	PharmGKB, RGD
PROSITE	KAZAL_2	UniProtKB/Swiss-Prot
Superfamily-SCOP	SSF103473	UniProtKB/Swiss-Prot
UniProt	A0A024R5I4	ENTREZGENE
	A0A0A0MTF1	ENTREZGENE, UniProtKB/TrEMBL
	A0A1B0GX35_HUMAN	UniProtKB/TrEMBL
	A8K2G9	ENTREZGENE
	B4DGA9	ENTREZGENE
	B4DTB0	ENTREZGENE
	C7BWB6_HUMAN	UniProtKB/TrEMBL
	C7BWB7_HUMAN	UniProtKB/TrEMBL
	E7ERN5	ENTREZGENE
	E9PI53_HUMAN	UniProtKB/TrEMBL
	E9PIU9_HUMAN	UniProtKB/TrEMBL
	E9PN87_HUMAN	UniProtKB/TrEMBL
	E9PPU8	ENTREZGENE
	E9PRW4	ENTREZGENE, UniProtKB/TrEMBL
	H0YE11_HUMAN	UniProtKB/TrEMBL
	O94956	ENTREZGENE
	Q9H2Z0	ENTREZGENE
	Q9UFU1	ENTREZGENE
	SO2B1_HUMAN	UniProtKB/Swiss-Prot
UniProt Secondary	A0A024R5I4	UniProtKB/Swiss-Prot
	A8K2G9	UniProtKB/Swiss-Prot
	B4DGA9	UniProtKB/Swiss-Prot
	B4DTB0	UniProtKB/Swiss-Prot
	E7ERN5	UniProtKB/Swiss-Prot
	E9PPU8	UniProtKB/Swiss-Prot
	Q9H2Z0	UniProtKB/Swiss-Prot
	Q9UFU1	UniProtKB/Swiss-Prot

Nomenclature History

Date	Current Symbol	Current Name	Previous Symbol	Previous Name	Description	Reference	Status
2015-11-24	SLCO2B1	solute carrier organic anion transporter family member 2B1		solute carrier organic anion transporter family, member 2B1	Symbol and/or name change	5135510	APPROVED

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Imported Disease Annotations - ClinVar

RGD Manual Annotations

Imported Human Phenotype Annotations - ClinVar

Send us a Message

Imported Disease Annotations - ClinVar

RGD Manual Annotations

Imported Human Phenotype Annotations - ClinVar